Submitted URL: http://link.email.empr.com/a/1323/click/68826/2303653/8ea590c244d7f9cee98d01044f61152677f30844/6fe7119f58b2152a2ec9475bf11c...
Effective URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=new...
Submission: On September 27 via api from US

Summary

This website contacted 46 IPs in 7 countries across 34 domains to perform 247 HTTP transactions. The main IP is 52.0.128.45, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.empr.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on January 16th 2019. Valid for: 2 years.
This is the only time www.empr.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 35.238.92.4 15169 (GOOGLE)
34 52.0.128.45 14618 (AMAZON-AES)
24 94.31.29.64 33438 (HIGHWINDS2)
3 2a00:1450:400... 15169 (GOOGLE)
1 93.184.220.113 15133 (EDGECAST)
6 2a00:1450:400... 15169 (GOOGLE)
4 52.216.171.93 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:20b... 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
10 172.217.16.194 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 6 2a00:1450:400... 15169 (GOOGLE)
1 4 2.19.43.224 20940 (AKAMAI-ASN1)
4 2a00:1450:400... 15169 (GOOGLE)
67 2606:4700:20:... 13335 (CLOUDFLAR...)
1 34.192.84.248 14618 (AMAZON-AES)
1 143.204.214.50 16509 (AMAZON-02)
3 2a03:2880:f01... 32934 (FACEBOOK)
2 2 54.156.255.160 14618 (AMAZON-AES)
2 2 35.227.248.159 15169 (GOOGLE)
1 34.225.65.223 14618 (AMAZON-AES)
1 143.204.207.113 16509 (AMAZON-02)
4 52.1.219.33 14618 (AMAZON-AES)
2 8 52.31.106.135 16509 (AMAZON-02)
2 2 2a00:1450:400... 15169 (GOOGLE)
2 5 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 143.204.214.113 16509 (AMAZON-02)
3 2a03:2880:f11... 32934 (FACEBOOK)
1 34.202.10.50 14618 (AMAZON-AES)
2 35.227.192.113 15169 (GOOGLE)
1 1 104.111.241.32 16625 (AKAMAI-AS)
2 2 35.190.72.21 15169 (GOOGLE)
2 2 2.18.233.201 16625 (AKAMAI-AS)
2 3 34.250.208.218 16509 (AMAZON-02)
2 3 18.197.149.199 16509 (AMAZON-02)
4 3.209.234.104 14618 (AMAZON-AES)
1 143.204.214.23 16509 (AMAZON-02)
8 2a00:1450:400... 15169 (GOOGLE)
4 34.197.62.58 14618 (AMAZON-AES)
4 2600:9000:20b... 16509 (AMAZON-02)
4 2600:1f14:e96... 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
2 143.204.214.75 16509 (AMAZON-02)
2 5 2600:1f14:e96... 16509 (AMAZON-02)
2 2600:1f14:e96... 16509 (AMAZON-02)
2 2600:1f14:e96... 16509 (AMAZON-02)
2 54.245.184.141 16509 (AMAZON-02)
1 2607:f8b0:400... 15169 (GOOGLE)
1 52.51.120.75 16509 (AMAZON-02)
247 46
Apex Domain
Subdomains
Transfer
69 lytics.io
c.lytics.io
api.lytics.io
82 KB
35 empr.com
link.email.empr.com
www.empr.com
media.empr.com
3 MB
24 netdna-ssl.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
405 KB
15 b2c.com
api.b2c.com
api-54-245-184-141.b2c.com
api-34-219-221-191.b2c.com
api-35-166-13-162.b2c.com
25 KB
14 googlesyndication.com
tpc.googlesyndication.com
pagead2.googlesyndication.com
125 KB
12 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
118 KB
9 ml314.com
ml314.com
in.ml314.com
17 KB
9 haymarketmedia.com
accounts.haymarketmedia.com
subapi.haymarketmedia.com
adtrackapi.haymarketmedia.com
12 KB
6 spotible.com
ads.spotible.com
cdn1.spotible.com
217 KB
6 google-analytics.com
www.google-analytics.com
40 KB
6 google.com
adservice.google.com
www.google.com
540 B
5 gstatic.com
fonts.gstatic.com
csi.gstatic.com
50 KB
5 googletagservices.com
www.googletagservices.com
130 KB
4 medtargetsystem.com
www.medtargetsystem.com
53 KB
4 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 amazonaws.com
s3.amazonaws.com
2 MB
4 crwdcntrl.net
tags.crwdcntrl.net
sync.crwdcntrl.net
bcp.crwdcntrl.net
13 KB
3 eyeota.net
ps.eyeota.net
1 KB
3 facebook.com
www.facebook.com
325 B
3 sitomobile.com
mt.sitomobile.com
sp.sitomobile.com
2 KB
3 facebook.net
connect.facebook.net
120 KB
3 google.de
adservice.google.de
www.google.de
389 B
3 googleapis.com
fonts.googleapis.com
2 KB
2 mathtag.com
pixel.mathtag.com
1 KB
2 rlcdn.com
idsync.rlcdn.com
849 B
2 adsrvr.org
js.adsrvr.org
insight.adsrvr.org
2 KB
2 tapad.com
pixel.tapad.com
841 B
2 maropost.com
content.maropost.com
mpct1.maropost.com
5 KB
1 thecardiologyadvisor.com
www.thecardiologyadvisor.com
210 KB
1 bluekai.com
tags.bluekai.com
856 B
1 alexametrics.com
certify.alexametrics.com
553 B
1 cloudfront.net
d31qbv1cthcecs.cloudfront.net
2 KB
1 crazyegg.com
script.crazyegg.com
28 KB
1 googletagmanager.com
www.googletagmanager.com
34 KB
247 34
Domain Requested by
67 c.lytics.io 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
c.lytics.io
www.empr.com
33 www.empr.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
24 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
10 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.empr.com
8 tpc.googlesyndication.com securepubads.g.doubleclick.net
www.empr.com
8 ml314.com 2 redirects www.empr.com
ml314.com
7 api-54-245-184-141.b2c.com 2 redirects www.empr.com
6 pagead2.googlesyndication.com www.empr.com
6 www.google-analytics.com 2 redirects www.googletagmanager.com
www.google-analytics.com
5 www.google.com 2 redirects securepubads.g.doubleclick.net
5 www.googletagservices.com www.empr.com
securepubads.g.doubleclick.net
4 api.b2c.com securepubads.g.doubleclick.net
www.empr.com
4 adtrackapi.haymarketmedia.com s3.amazonaws.com
4 ads.spotible.com www.empr.com
ads.spotible.com
4 subapi.haymarketmedia.com s3.amazonaws.com
4 www.medtargetsystem.com www.empr.com
www.medtargetsystem.com
4 fonts.gstatic.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
4 sb.scorecardresearch.com 1 redirects www.empr.com
www.googletagmanager.com
4 s3.amazonaws.com www.empr.com
3 ps.eyeota.net 2 redirects www.empr.com
3 www.facebook.com www.empr.com
connect.facebook.net
3 connect.facebook.net www.empr.com
connect.facebook.net
3 fonts.googleapis.com www.empr.com
s3.amazonaws.com
2 api-35-166-13-162.b2c.com www.empr.com
2 api-34-219-221-191.b2c.com www.empr.com
2 cdn1.spotible.com www.empr.com
2 sync.crwdcntrl.net 2 redirects
2 pixel.mathtag.com 2 redirects
2 idsync.rlcdn.com 2 redirects
2 api.lytics.io c.lytics.io
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
2 www.google.de www.empr.com
2 stats.g.doubleclick.net 2 redirects
2 pixel.tapad.com 2 redirects
2 mt.sitomobile.com 2 redirects
1 insight.adsrvr.org js.adsrvr.org
1 bcp.crwdcntrl.net tags.crwdcntrl.net
1 csi.gstatic.com securepubads.g.doubleclick.net
1 www.thecardiologyadvisor.com www.empr.com
1 media.empr.com www.empr.com
1 tags.bluekai.com 1 redirects
1 in.ml314.com ml314.com
1 certify.alexametrics.com www.empr.com
1 js.adsrvr.org www.googletagmanager.com
1 sp.sitomobile.com www.empr.com
1 d31qbv1cthcecs.cloudfront.net www.empr.com
1 accounts.haymarketmedia.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
1 mpct1.maropost.com content.maropost.com
1 script.crazyegg.com www.googletagmanager.com
1 adservice.google.com www.googletagservices.com
1 adservice.google.de www.googletagservices.com
1 content.maropost.com www.empr.com
1 www.googletagmanager.com www.empr.com
1 tags.crwdcntrl.net www.empr.com
1 link.email.empr.com 1 redirects
247 54
Subject Issuer Validity Valid
*.empr.com
RapidSSL RSA CA 2018
2019-01-16 -
2021-01-15
2 years crt.sh
*.netdna-ssl.com
Sectigo RSA Domain Validation Secure Server CA
2019-02-18 -
2020-02-27
a year crt.sh
*.googleapis.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
tags.crwdcntrl.net
DigiCert SHA2 Secure Server CA
2019-03-15 -
2021-04-07
2 years crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2019-09-06 -
2020-12-02
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
content.maropost.com
Amazon
2018-10-25 -
2019-11-25
a year crt.sh
*.google.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
ssl945600.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-20 -
2020-02-26
6 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.maropost.com
Go Daddy Secure Certificate Authority - G2
2019-06-10 -
2021-08-09
2 years crt.sh
ssl379818.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-07-26 -
2020-02-01
6 months crt.sh
accounts.haymarketmedia.com
Amazon
2018-10-26 -
2019-11-26
a year crt.sh
*.cloudfront.net
DigiCert Global CA G2
2019-07-17 -
2020-07-05
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-08-24 -
2019-10-19
2 months crt.sh
*.sitomobile.com
RapidSSL RSA CA 2018
2018-01-22 -
2020-07-29
3 years crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1
2019-03-07 -
2021-04-19
2 years crt.sh
medtargetsystem.com
Amazon
2018-11-23 -
2019-12-23
a year crt.sh
*.ml314.com
Amazon
2019-03-16 -
2020-04-16
a year crt.sh
www.google.de
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
certify.alexametrics.com
Amazon
2019-07-26 -
2020-08-26
a year crt.sh
*.lytics.io
RapidSSL TLS RSA CA G1
2018-01-26 -
2020-01-06
2 years crt.sh
*.eyeota.net
Let's Encrypt Authority X3
2019-09-19 -
2019-12-18
3 months crt.sh
subapi.haymarketmedia.com
Amazon
2019-06-28 -
2020-07-28
a year crt.sh
empr.com
Amazon
2018-11-08 -
2019-12-08
a year crt.sh
*.thecardiologyadvisor.com
RapidSSL RSA CA 2018
2019-02-20 -
2020-02-20
a year crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
*.spotible.com
Go Daddy Secure Certificate Authority - G2
2016-10-16 -
2019-11-06
3 years crt.sh
adtrackapi.haymarketmedia.com
Amazon
2019-03-27 -
2020-04-27
a year crt.sh
www.google.com
GTS CA 1O1
2019-09-05 -
2019-11-28
3 months crt.sh
*.b2c.com
Amazon
2019-03-24 -
2020-04-24
a year crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2019-06-13 -
2021-06-28
2 years crt.sh

This page contains 11 frames:

Primary Page: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Frame ID: 5840B2FF783FB1E18AD9AE7AA13F39D1
Requests: 204 HTTP requests in this frame

Frame: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/c9e52fb98fb2fcfc524217f74e5d616e?segments=true&mergestate=true&ts=1569558852242
Frame ID: D76B823BA129383C6C7A6DFB0C2E63AA
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 2AB4BA6A091E92C83697D13764405EF8
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 07A4FEA217379A2E40E7429F50E5877A
Requests: 1 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F&_sid=00c6e604-5dce-41b5-b436-9f749f08c579&_vid=1583796a-0775-42c7-a5cf-462160a1497f&_ak=35-212-8F62AC13&_flash=false&_th=1569558852|1569558852|1
Frame ID: A9A6FE5D55DF89093418242DE2E0C630
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 95923AA737316EB2D6B55E43AB6DD447
Requests: 2 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/error_handler.js
Frame ID: DA70C81739682DE80D6BCAE71CD8B973
Requests: 18 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsueukiquG4I3jAoa3Y1jJgcD4rVtEgoBntEr7eyJEgvP0fbsgrTtEOgvZoT8yOGi_bw-JLqWkeKunbjQgP_16uvkb2oS86lgQJYWk1kjQ5g0yg5K9UlGeS8NPH2p_wPFb2PEZ4X9Ql_TzKTNai75KFexnAxVdzeroZ9tAoijURKxHSp3ttzcFMuTRZgwHQFnGbpNAXWoquCP1uwBr-as3O-aityjNYZaf9kyBPJPa2rh1Jg-rmrQE0g_iWHtoFpaRvNnOvZdCMp5w&sig=Cg0ArKJSzPuWgMGVe-i7EAE&adurl=
Frame ID: 841653DCA868DF402EBE3EAF5E5C1BFD
Requests: 11 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/error_handler.js
Frame ID: E76FFFB98B4AF8224220B542B258D835
Requests: 14 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/c=14413/rand=724066507/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/med=%23OpR%2397539%23Article%20Tags%20%3A%20Oncology%2CRespiratory%20and%20Thoracic%20Cancers/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653%22%7D/rt=ifr
Frame ID: A0D526A5204167FF4A27132026F019BC
Requests: 1 HTTP requests in this frame

Frame: https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&upid=7fhq4wn&upv=1.1.0
Frame ID: 113E7BF8F18F5F6FC6FC9380652B2493
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://link.email.empr.com/a/1323/click/68826/2303653/8ea590c244d7f9cee98d01044f61152677f30844/6fe7119f... HTTP 302
    https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-n... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

247
Requests

97 %
HTTPS

43 %
IPv6

34
Domains

54
Subdomains

46
IPs

7
Countries

5982 kB
Transfer

8373 kB
Size

9
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://link.email.empr.com/a/1323/click/68826/2303653/8ea590c244d7f9cee98d01044f61152677f30844/6fe7119f58b2152a2ec9475bf11c05168b614aa0&amp HTTP 302
    https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1569558851627&ns_c=UTF-8&c8=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558851627&ns_c=UTF-8&c8=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9=
Request Chain 56
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://mt.sitomobile.com/sync/tacb?exid=0eace9e1-e0e0-11e9-8dcb-52c7686934ad&aid=136&sid=hmm&val=12 HTTP 302
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Request Chain 63
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1133661135&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&ul=en-us&de=UTF-8&dt=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAAAAjQ~&jid=451128824&gjid=542805172&cid=1264205446.1569558852&tid=UA-1290429-2&_gid=1867887594.1569558852&_r=1&gtm=2wg9i15XFK9V6&cd1=124022%3A0&cd2=oncology%2Crespiratory%20and%20thoracic%20cancers&cd3=&cd4=&cd5=post&cd6=&cd7=home&cd8=news&cd9=nivolumab%20vs%20docetaxel&cd11=omn&cd12=13&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=Brian%20Park%2C%20PharmD&cd35=MPR%20Drug%20News&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=9&cd57=&cd58=&cd62=false&cd63=2019-09-17&cd64=330&cd67=&cd68=undef&cd71=false&cd78=false&cd79=false&cd80=false&cd93=news&cd94=placeholder&z=1763046452 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_gid=1867887594.1569558852&gjid=542805172&_v=j79&z=1763046452 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_v=j79&z=1763046452 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_v=j79&z=1763046452&slf_rd=1&random=2591504702
Request Chain 71
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151501698431723&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151501698431723%26eid=50056 HTTP 302
  • https://ml314.com/csync.ashx?fp=M1lpBQ9999OeyRN5&person_id=5978151501698431723&eid=50056
Request Chain 72
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151501698431723 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTUwMTY5ODQzMTcyMxAAGg0IxKK27AUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=34ba23456f3a59b6912852b934c1b5192ccc8c25021aa66fbd3c55ac3cad96c3f4cb09cee1a4f8eb&person_id=5978151501698431723&eid=50082
Request Chain 73
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501698431723%26eid=50220 HTTP 302
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501698431723%26eid=50220&mm_bnc&mm_bct&UUID=a6ab5d8d-8bf9-4d00-853a-7fba17ded2f4 HTTP 302
  • https://ml314.com/csync.ashx?fp=a6ab5d8d-8bf9-4d00-853a-7fba17ded2f4&person_id=5978151501698431723&eid=50220
Request Chain 74
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501698431723 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501698431723 HTTP 302
  • https://ml314.com/csync.ashx?fp=b1cbf696db8ce881be614625f59d966e&eid=50146&person_id=5978151501698431723
Request Chain 75
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif HTTP 302
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif HTTP 302
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2RK9XQOLmMR1wNyXG6QeoYTMCyZNh96anvJzqOhELR0g&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil HTTP 302
  • https://ml314.com/csync.ashx?fp=2RK9XQOLmMR1wNyXG6QeoYTMCyZNh96anvJzqOhELR0g&person_id=5978151501698431723&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil HTTP 302
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Request Chain 233
  • https://api-54-245-184-141.b2c.com/api/x?etqib3p9aTEaLXl1$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 HTTP 302
  • https://api-54-245-184-141.b2c.com:444/api/4?etqib3p9aTEaLXl1
Request Chain 234
  • https://api-34-219-221-191.b2c.com/api/x?3GPX0VNSMyR66jQt$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 HTTP 302
  • https://api-34-219-221-191.b2c.com:444/api/4?3GPX0VNSMyR66jQt
Request Chain 235
  • https://api-35-166-13-162.b2c.com/api/x?MU8eTtoZbjjRInus$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 HTTP 302
  • https://api-35-166-13-162.b2c.com:444/api/4?MU8eTtoZbjjRInus
Request Chain 244
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1133661135&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&ul=en-us&de=UTF-8&dt=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=lytics_refresh&ea=undefined&_u=aGjAAAAjQ~&jid=2098950621&gjid=82973732&cid=1264205446.1569558852&tid=UA-1290429-2&_gid=1796489758.1569558855&_r=1&gtm=2wg9i15XFK9V6&cd20=ga_med_nomycme%2Cga_med_nht_false%2Call%2Cga_med_known&cd21=&cd22=&cd23=&cd24=&cd25=&cd26=&cd27=&cd28=&cd29=&cd30=Normal%20(74%20segments%20found)&z=1880946211 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_gid=1796489758.1569558855&gjid=82973732&_v=j79&z=1880946211 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_v=j79&z=1880946211 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_v=j79&z=1880946211&slf_rd=1&random=427057369
Request Chain 251
  • https://api-54-245-184-141.b2c.com/api/x?MIm1Xl62paofqMpJ$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 HTTP 302
  • https://api-54-245-184-141.b2c.com:444/api/4?MIm1Xl62paofqMpJ

247 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/
Redirect Chain
  • http://link.email.empr.com/a/1323/click/68826/2303653/8ea590c244d7f9cee98d01044f61152677f30844/6fe7119f58b2152a2ec9475bf11c05168b614aa0&amp
  • https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_m...
103 KB
22 KB
Document
General
Full URL
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
18695ec49f0199c409972e329bdfb524a34cf94471ce1516ab3d39e142d5045a

Request headers

:method
GET
:authority
www.empr.com
:scheme
https
:path
/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
server
nginx
date
Fri, 27 Sep 2019 04:34:11 GMT
content-type
text/html; charset=UTF-8
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-distributor
yes
x-pingback
https://www.empr.com/xmlrpc.php
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/" <https://www.empr.com/?p=124022>; rel=shortlink
x-cacheable
SHORT
cache-control
max-age=600, must-revalidate
x-cache
MISS
x-pass-why
x-cache-group
normal
x-wpengine-segment
NONHT
content-encoding
gzip

Redirect headers

Content-Type
text/html; charset=utf-8
Transfer-Encoding
chunked
Connection
keep-alive
Status
302 Found
Cache-Control
no-cache
X-XSS-Protection
1; mode=block
X-Request-Id
7eedd80e-60f2-4466-8d6f-0c985dc88a69
Location
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
X-Runtime
0.026883
X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
Date
Fri, 27 Sep 2019 04:34:10 GMT
Set-Cookie
_session_id=54ff58c553b7ea9e0afb8ac18010f98e; path=/; expires=Fri, 27 Sep 2019 16:34:10 -0000; HttpOnly
X-Powered-By
Phusion Passenger 5.3.4
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/
29 KB
5 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/style.min.css?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Mon, 22 Apr 2019 12:40:04 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cbdb624-726f"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
shared-style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
48 KB
7 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-c05a"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
240 KB
32 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f1e3884dae2f0ddd32795c0c1ac83e9f9a8c7dce35dbd784bdc3c9872196bb1c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-3bfb4"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
8 KB
860 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 27 Sep 2019 04:34:11 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 27 Sep 2019 04:34:11 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:11 GMT
lytics.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/
39 KB
3 KB
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6944e75951f2e7bf00121eea502e7d952a833e811e13a1f28fb077df6af721f3

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-9de9"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
css
fonts.googleapis.com/
825 B
409 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Bree+Serif&ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 27 Sep 2019 04:34:11 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 27 Sep 2019 04:34:11 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:11 GMT
autosuggest.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/
766 B
581 B
Stylesheet
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/autosuggest.min.css?ver=3.1.4
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-2fe"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=31536000
jquery.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
95 KB
34 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Fri, 17 May 2019 17:08:53 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cdeeaa5-17a69"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
jquery-migrate.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/
10 KB
4 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Fri, 20 May 2016 06:11:28 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"573eaa90-2748"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cookie.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-834"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
cc.js
tags.crwdcntrl.net/c/14413/
39 KB
11 KB
Script
General
Full URL
https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
93.184.220.113 London, United Kingdom, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (amb/6B94) /
Resource Hash
207775987f53f3b91160546806345706ec562f294cb076637004e36d81ef221b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 01:01:17 GMT
server
ECS (amb/6B94)
etag
"5d7998dd-9b68+gzip"
vary
Accept-Encoding
x-cache
HIT
content-type
application/javascript
status
200
cache-control
max-age=86400
content-length
11493
expires
Sat, 28 Sep 2019 04:34:11 GMT
digest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
16 KB
5 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/digest.min.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Wed, 22 May 2019 09:37:40 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5ce51864-3fc1"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
UtilityMove-custom.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/
2 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-751"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
polyfill.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/
102 KB
35 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-19873"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
gpt.js
www.googletagservices.com/tag/js/
44 KB
14 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
d80e5839d198279a97915c6ca1069c537210b27ab7327b12aca428639134e0c9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"291 / 480 of 1000 / last-modified: 1569527018"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14244
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:11 GMT
adtracking.js
s3.amazonaws.com/haymarket-adtracking-js/prod/
19 KB
19 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.171.93 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Last-Modified
Tue, 15 Jan 2019 22:54:19 GMT
Server
AmazonS3
x-amz-request-id
11B70013E5C23D73
ETag
"dc289fc811d6d3a62b068bfcda1f8f30"
Content-Type
application/javascript
x-amz-version-id
MlU6AsBGwcOjZYgQIgNYntESpQyo9BbN
Accept-Ranges
bytes
Content-Length
19158
x-amz-id-2
BrWalsFBx7KFBC/6CYbUNcz2DCwTcojb2cPmWWLoID9nbO72XSIHiP5XIO9ECUZWKNYU0sAH/hE=
head.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
44 KB
13 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/head.min.js?ver=1569414182
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3463d937369067ba4b7700dd056500a6d9d28fed29addce4e3bce87a0970a348

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Wed, 25 Sep 2019 12:23:02 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d8b5c26-aebf"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
MPR-logo_website.png
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/
16 KB
16 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/MPR-logo_website.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
etag
"452a9f099947d43a38734d72a92e9193"
last-modified
Wed, 20 Mar 2019 21:55:07 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
16492
expires
Sat, 19 Oct 2019 17:51:07 GMT
gtm.js
www.googletagmanager.com/
139 KB
34 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
b92a2e8779df445c71f7253608ef7526db31a5cfda1130a0df33c5e2f554f344
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
br
last-modified
Fri, 27 Sep 2019 03:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35074
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:11 GMT
Park_Brian-150x150.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/05/
15 KB
15 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/05/Park_Brian-150x150.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
de709acbe98dba4f2f3fc3204a09a5add553a366b33501d54f78b5f263775785
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
etag
"5c39283ae49b2ce7914cb7d8d198c8a8"
last-modified
Tue, 20 Aug 2019 07:11:14 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
14921
expires
Tue, 22 Oct 2019 21:14:32 GMT
Lung-Cancer-2.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/04/
167 KB
168 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/04/Lung-Cancer-2.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
a0761809c73e189d660329b14a3d67b4ed30f0666b226feb844e17eb91c852bb
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
etag
"4bd27228dc976282bda63a59ea0ad792"
last-modified
Wed, 24 Apr 2019 07:11:45 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
MISS
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
171071
expires
Sun, 27 Oct 2019 04:34:11 GMT
300x100mprsub-300x105.gif
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/
13 KB
14 KB
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/300x100mprsub-300x105.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
etag
"fb86d90a5bcf340b8bd64802ec39a7a5"
last-modified
Wed, 20 Mar 2019 09:05:43 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/gif
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
13667
expires
Sat, 19 Oct 2019 18:15:46 GMT
spinner.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/src/
694 B
631 B
Image
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js
content.maropost.com/uploads/1323/websites/5/
3 KB
3 KB
Script
General
Full URL
https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:c000:1b:fadc:b780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 23 Sep 2019 19:08:41 GMT
via
1.1 a853d87afe2972a208a9cd92a357386b.cloudfront.net (CloudFront)
last-modified
Thu, 27 Sep 2018 21:48:02 GMT
server
AmazonS3
age
31139
etag
"ff4375eccda3ca6bc54ed96c5d77d9bb"
x-cache
Hit from cloudfront
status
200
x-amz-cf-pop
FRA56
accept-ranges
bytes
content-length
2622
x-amz-cf-id
-HFfPsVYwgB664H7Co6ndgmHupUXQxRZyVc6kXInHb5uDsOct8F_Cg==
blocks.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
7 KB
3 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3ed3de3fd0fabc795d8b96ada205998944ff3157366f20b70d5d10b099b63120

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1b42"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
local-storage-lib.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
1 KB
918 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/local-storage-lib.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Wed, 17 Jul 2019 13:03:16 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d2f1c94-591"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
npi-manager.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/
3 KB
1 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/npi-manager.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
43a5ba666207ae3718ce7fe6b4015c58043b4ac4dfdacae285d5d8574d80fdf6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-b3b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
hmi-registration-ui.manifest.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
799 B
1 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.171.93 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
43C4DE11C52526C1
ETag
"6878a8fbe72bde4a3f8ecf5b16523972"
Content-Type
application/javascript
x-amz-version-id
csLBKnYjTffo31CifRF6x383B2E_amuJ
Accept-Ranges
bytes
Content-Length
799
x-amz-id-2
6P2KiSIycaPiPq1u3wdk3jqNz2heJR9Mf4df3115lYHGHCkZUmN5tMooL0z9tfbQLeNEWckZQj8=
hmi-registration-ui.vendor.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
357 KB
357 KB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.171.93 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
2673f6b0416b9a9f7488ee96f384f5badfa04acb14499c92ae52e394b7572f1f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
0C958B579E20C39F
ETag
"dfdfd93abc9eec4ff346a12a61df7c41"
Content-Type
application/javascript
x-amz-version-id
6ACuZZ4Fakkhaw3IL9mD952B0XZGZK4Q
Accept-Ranges
bytes
Content-Length
365119
x-amz-id-2
9l64uVqe+2p3YVncan5cuhq1L7CLU5QDVpI63vu0IvhXJvzhiHt9WWECztFk6aos2fdPQjhcZlg=
hmi-registration-ui.bundle.js
s3.amazonaws.com/haymarket-reg-js/develop/production/
1 MB
1 MB
Script
General
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.171.93 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4eef9cbbcb01ac2538e54c45514c0560e686abf17070adfba489fd1b3b86455a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
4E35160D04E76107
ETag
"8f47379688c3f5980d42b891fcaea0eb"
Content-Type
application/javascript
x-amz-version-id
1g9qbXhjK6v_p1EyiVTzg_c7stFBXUFD
Accept-Ranges
bytes
Content-Length
1225121
x-amz-id-2
SI5UiiQVqNyfPToVcdYSOpW8+PblQ3B7mHXaopWIfTcix+w0XR61g5NHM5vsNJEglq3yOeg7ckY=
autosuggest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/
17 KB
5 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/autosuggest.min.js?ver=3.1.4
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6258dbe6dbce7a7de872ad56d9ceea8354f5d37626e66201ec29b2717a95e949

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-4361"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
frontend.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
147 KB
39 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
be6beaacd90961241ca111e54c0953bc476a844a264e5afade4792a75c78c540

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 12 Sep 2019 09:51:52 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d7a1538-24c66"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
iab.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/
8 KB
2 KB
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6463301e10c71f76fc14bb977dfa9097b5633ed4a3ee4119abccf2ead9aa9e29

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1ecd"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
wp-embed.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/
1 KB
1004 B
Script
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/wp-embed.min.js?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Thu, 30 Aug 2018 12:40:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5b87e5ba-57b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
integrator.js
adservice.google.de/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019091901.js
securepubads.g.doubleclick.net/gpt/
156 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
c77635c1d346c5471d294f59d0c4ef11f71c21f94e82087cbd99984c9aaa3cda
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 19 Sep 2019 13:07:51 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58568
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:12 GMT
7341.js
script.crazyegg.com/pages/scripts/0034/
88 KB
28 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0034/7341.js?435988
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
8617f3b621a7fe14ab36ef607fda9909163c458e72f24f0836fb0158a5e31f83

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
via
1.1 04ce5a607a98db6d08257633417b84d7.cloudfront.net (CloudFront)
cf-cache-status
HIT
age
2122
cf-polished
origSize=89761
x-cache
Hit from cloudfront
status
200
content-encoding
gzip
last-modified
Wed, 25 Sep 2019 17:06:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
private, max-age=300
x-amz-cf-pop
FRA2-C2
cf-ray
51cac388bb265988-VIE
x-amz-cf-id
bgSABxQQehjngADKxBsDyOjIDQya34o6WaHTLGcNWBLISn9j59kvLw==
cf-bgj
minify
analytics.js
www.google-analytics.com/
43 KB
17 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
493
date
Fri, 27 Sep 2019 04:25:58 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
17803
expires
Fri, 27 Sep 2019 06:25:58 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1569558851627&ns_c=UTF-8&c8=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&c7=https%...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558851627&ns_c=UTF-8&c8=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&c7=https...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558851627&ns_c=UTF-8&c8=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:12 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1569558851627&ns_c=UTF-8&c8=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&c9=
Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:12 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
src.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/
33 KB
10 KB
Other
General
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811

Request headers

Sec-Fetch-Mode
same-origin
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-8317"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wXiWtFCc.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 13:36:09 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:55 GMT
server
sffe
age
2732282
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14044
x-xss-protection
0
expires
Tue, 25 Aug 2020 13:36:09 GMT
chevron-right-white.svg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/
190 B
400 B
Image
General
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/chevron-right-white.svg
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:11 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-be"
vary
Accept-Encoding
x-cache
HIT
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=31536000
BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 26 Aug 2019 13:27:01 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:27:03 GMT
server
sffe
age
2732830
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11388
x-xss-protection
0
expires
Tue, 25 Aug 2020 13:27:01 GMT
BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
fonts.gstatic.com/s/robotoslab/v9/
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 02 Sep 2019 15:53:22 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:19:23 GMT
server
sffe
age
2119249
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11272
x-xss-protection
0
expires
Tue, 01 Sep 2020 15:53:22 GMT
S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v16/
14 KB
14 KB
Font
General
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 21 Aug 2019 21:19:20 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:54 GMT
server
sffe
age
3136491
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14176
x-xss-protection
0
expires
Thu, 20 Aug 2020 21:19:20 GMT
js
www.google-analytics.com/gtm/
56 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-T8P2ZZ9&t=gtm1&cid=1264205446.1569558852
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
2b9d553068a82437949fb7f332ecf746c87fb1a8abedf7dc231a6026030f5c38
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
content-encoding
br
last-modified
Fri, 27 Sep 2019 03:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
21298
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:12 GMT
96ac8580a54c3864c4ba15ff4a38efdcb7084985.js
mpct1.maropost.com/accounts/1323/websites/5/track/
4 KB
3 KB
Script
General
Full URL
https://mpct1.maropost.com/accounts/1323/websites/5/track/96ac8580a54c3864c4ba15ff4a38efdcb7084985.js?contact_id=2303653&campaign_id=68826&title=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&url=https%3A%2F%2Fempr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&
Requested by
Host: content.maropost.com
URL: https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.238.92.4 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
4.92.238.35.bc.googleusercontent.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.4 / Phusion Passenger 5.3.4
Resource Hash
246b0a78bda574c3a7d5187e7f4339843119875a6546a1752227fe2aa4d787b1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-Powered-By
Phusion Passenger 5.3.4
Transfer-Encoding
chunked
Status
200 OK
Connection
keep-alive
Vary
Accept-Encoding
X-XSS-Protection
1; mode=block
X-Request-Id
ca8363a2-362a-4b5a-8365-b6716122d669
X-Runtime
0.034737
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
ETag
W/"a5b68ab4808a128454a8d7bca674ab82"
X-Frame-Options
SAMEORIGIN
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=0, private, must-revalidate
lio.js
c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/
45 KB
11 KB
Script
General
Full URL
https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac3893d66cba0-VIE
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
24
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:34:12 GMT
most-widget
www.empr.com/wp-json/haymarket/v1/
4 KB
2 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/most-widget?id=most-5
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
169b598c2a86576823e1068924ba6325c973d3250c9464ff3ea0e0fcbd73cf01
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 11
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
124022
www.empr.com/wp-json/haymarket/v1/infinite-scroll/
10 KB
3 KB
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/infinite-scroll/124022
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a3c8ed44e96cb94384aaa868489751501613381753b090c1c867cbd4dd0e96f6
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
MISS
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
partial-login
www.empr.com/wp-json/haymarket/v1/
634 B
839 B
XHR
General
Full URL
https://www.empr.com/wp-json/haymarket/v1/partial-login?subid=&subemail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ad16911f49d3e72d789bfe438841576129e86d69f42bcaddf489d3523ed69951
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 1
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
/
accounts.haymarketmedia.com/sso/check/
45 B
441 B
XHR
General
Full URL
https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.192.84.248 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-192-84-248.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
x-aspnetmvc-version
4.0
server
Microsoft-IIS/8.5
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.empr.com
cache-control
private
access-control-allow-credentials
true
content-length
45
atrk.js
d31qbv1cthcecs.cloudfront.net/
4 KB
2 KB
Script
General
Full URL
https://d31qbv1cthcecs.cloudfront.net/atrk.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.50 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-50.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
90451ba3e82cd9db02f0ca76bd45d0ab5ef7e90a49da4215903cb7f08471e2e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Wed, 26 Jun 2019 00:49:33 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Sat, 16 Mar 2019 16:01:33 GMT
Server
AmazonS3
Age
8048680
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
text/javascript
Via
1.1 511c8b6c7e903efca023a504d527516b.cloudfront.net (CloudFront)
Cache-Control
max-age=26920000
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA53-C1
X-Amz-Cf-Id
S3e5xIzQcbHNT-fbpApjrc8iosRESrDAzh2DryXUsa61lLzDgmfqXA==
gg.js
sb.scorecardresearch.com/rs/pt/
2 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Content-Encoding
gzip
Connection
keep-alive
X-N
S
Content-Length
1246
Vary
Accept-Encoding
Content-Type
application/x-javascript
fbevents.js
connect.facebook.net/en_US/
121 KB
32 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
14d88b3a27f0e6de034f86ad42d6411081e9467daf754147f2f16bcb20782177
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
31604
x-xss-protection
0
pragma
public
x-fb-debug
Dw14h4pXG7zLzJuoCovGMDTXgTrHT2Ny2NKKk4kL2Gbly48s1WFeUi18NsgEGsq82qo9S2gWlNkiImjmhZk5tA==
x-fb-trip-id
194532234
x-frame-options
DENY
date
Fri, 27 Sep 2019 04:34:12 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
i
sp.sitomobile.com/
Redirect Chain
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://mt.sitomobile.com/sync/tacb?exid=0eace9e1-e0e0-11e9-8dcb-52c7686934ad&aid=136&sid=hmm&val=12
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5...
43 B
388 B
Script
General
Full URL
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy9jb250ZXh0cy9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6W3sic2NoZW1hIjoiaWdsdTpjb20uc2l0b21vYmlsZS5zbm93cGxvdy90YXBhZF9jb250ZXh0L2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InRhcGFkSWQiOiIwZWFjZTllMS1lMGUwLTExZTktOGRjYi01MmM3Njg2OTM0YWQifX0seyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L3NpdG9fY2FtcGFpZ25fY29udGV4dC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJhZHZlcnRpc2VySWQiOiIxMzYiLCJjYW1wYWlnbklkIjoiIiwibGluZUl0ZW1JZCI6IiJ9fSx7InNjaGVtYSI6ImlnbHU6Y29tLnNpdG9tb2JpbGUuc25vd3Bsb3cvc2VnbWVudF9jb250ZXh0L2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InNlZ21lbnRJZCI6ImhtbSIsInNlZ21lbnRWYWwiOiIxMiJ9fV19
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.225.65.223 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-65-223.compute-1.amazonaws.com
Software
Apache-Coyote/1.1 /
Resource Hash
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Server
Apache-Coyote/1.1
Connection
keep-alive
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR NID PSA OUR IND COM NAV STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Server
nginx/1.12.1
X-Powered-By
Express
Vary
Accept
Content-Type
text/plain; charset=utf-8
Location
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Connection
keep-alive
Content-Length
972
up_loader.1.1.0.js
js.adsrvr.org/
6 KB
2 KB
Script
General
Full URL
https://js.adsrvr.org/up_loader.1.1.0.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.207.113 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-207-113.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Thu, 26 Sep 2019 19:04:39 GMT
Content-Encoding
gzip
Last-Modified
Wed, 17 Jul 2019 18:26:10 GMT
Server
AmazonS3
Age
34260
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 1cc446ef4692d8e752b16c07f2f58a59.cloudfront.net (CloudFront)
Connection
keep-alive
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA53-C1
X-Amz-Cf-Id
4U8-VCCPp40kioiVbIqXXtIUwBAWjhsTCHEapNMHSGktXFJcyMC-Hg==
beacon.js
www.medtargetsystem.com/javascript/
176 KB
52 KB
Script
General
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
96c02a809234415c196ffe1c2f4c0c87078ca7eaea213ebc7d8c9e5800c60764

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Content-Encoding
gzip
Last-Modified
Fri, 06 Sep 2019 19:17:45 GMT
Server
Apache/2.4.7 (Ubuntu)
ETag
"2c187-591e74afb2840-gzip"
Vary
X-Forwarded-Proto,Accept-Encoding
Content-Type
application/javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
52901
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
926 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 03:40:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
3223
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
856
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:40:29 GMT
tag.aspx
ml314.com/
26 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?2782019
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
7d655e8cd62ba58d86b3bc9c8e1e04a76506a4dfc852c3b3813deb0aef284548

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:11 GMT
Content-Encoding
gzip
Last-Modified
Thu, 26 Sep 2019 05:39:48 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=3936
Connection
keep-alive
Content-Length
11933
Expires
Fri, 27 Sep 2019 05:39:48 GMT
io.min.js
c.lytics.io/static/v2/
13 KB
6 KB
Script
General
Full URL
https://c.lytics.io/static/v2/io.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
1c0e0ca6ba3ee267ba14d39184efb68c958717fc6e58b528b700502c0aea5170

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac3897dd3cba0-VIE
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Fri, 13 Sep 2019 19:02:47 GMT
server
cloudflare
age
6606
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:34:12 GMT
1073716492693685
connect.facebook.net/signals/config/
307 KB
78 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1073716492693685?v=2.9.4&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
79754
x-xss-protection
0
pragma
public
x-fb-debug
Ku771L1PPOlMX6ACX8Ai+wlgNEMQ+OmItIGFAKU6CFe38MrnRjvfOgU2juYJdkG+V+Y+jdyn+OK3seTRBNmzBA==
x-fb-trip-id
194532234
x-frame-options
DENY
date
Fri, 27 Sep 2019 04:34:12 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1133661135&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsc...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_gid=1867887594.1569558852&gjid=542805172&_v=j79&z=1763046452
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_v=j79&z=1763046452
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_v=j79&z=1763046452&slf_rd=1&random=2591504702
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_v=j79&z=1763046452&slf_rd=1&random=2591504702
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=451128824&_v=j79&z=1763046452&slf_rd=1&random=2591504702
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
4
c.lytics.io/cid/
78 B
196 B
Script
General
Full URL
https://c.lytics.io/cid/4?callback=jQuery1124039028706523702383_1569558851534&_=1569558851535
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
ff01bc50cd42860b7fad9e3ff5a6054d9191a9b3e0baba23aa7fb9a632013f26

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac389ae17cba0-VIE
pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
content-encoding
br
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
expires
0
inferredEvents.js
connect.facebook.net/signals/plugins/
35 KB
10 KB
Script
General
Full URL
https://connect.facebook.net/signals/plugins/inferredEvents.js?v=2.9.4
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
b4e9e9bef19c34422f55a7fdb9d10c4db5e39cff24b8c98a0be0e09b2ee6ac2b
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
10218
x-xss-protection
0
pragma
public
x-fb-debug
XD+jPKOTQiEcQqY+fZ4lH21OPCoB0kuuo/T8KNiAJxnmL+wH2Q4rOxl9tT8hhgxzejAekplxC2FiCYKXtlMmCQ==
x-fb-trip-id
194532234
x-frame-options
DENY
date
Fri, 27 Sep 2019 04:34:12 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
atrk.gif
certify.alexametrics.com/
43 B
553 B
Image
General
Full URL
https://certify.alexametrics.com/atrk.gif?frame_height=1200&frame_width=1600&iframe=0&title=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&time=1569558852115&time_zone_offset=-120&screen_params=1600x1200x24&java_enabled=0&cookie_enabled=1&ref_url=&host_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&random_number=8388979539&sess_cookie=70ea8bb016d70ff72138ac4f9b1&sess_cookie_flag=1&user_cookie=70ea8bb016d70ff72138ac4f9b1&user_cookie_flag=1&dynamic=true&domain=empr.com&account=gujPp1NErb205V&jsv=20130128&user_lang=en-US
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.113 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-113.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Thu, 26 Sep 2019 04:50:06 GMT
Via
1.1 80d90c7955dda88e3912960ead8e99d6.cloudfront.net (CloudFront)
Last-Modified
Mon, 17 Jan 2011 20:41:40 GMT
Server
AmazonS3
Age
113768
ETag
"221d8352905f2c38b3cb2bd191d630b0"
X-Cache
Hit from cloudfront
Content-Type
image/gif
Connection
keep-alive
Accept-Ranges
bytes
X-Amz-Cf-Pop
FRA53-C1
x-amz-meta-alexa-last-modified
20110117123941
Content-Length
43
X-Amz-Cf-Id
_u9fVOC34J3I3H7Ii9D2fOJ1SiE0QEXdvfBwv4q6TPDNUS4azCXokQ==
/
www.facebook.com/tr/
44 B
325 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1073716492693685&ev=PageView&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&rl=&if=false&ts=1569558852120&sw=1600&sh=1200&v=2.9.4&r=stable&ec=0&o=30&fbp=fb.1.1569558852119.421301423&it=1569558852085&coo=false&rqm=GET
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
content-length
44
expires
Fri, 27 Sep 2019 04:34:12 GMT
utsync.ashx
ml314.com/
793 B
2 KB
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=740&ct=js&pi=&fp=&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&pv=1569558852206_2o1k38fw8&bl=en-us&cb=3128027&return=&ht=&d=&dc=&si=1569558852206_2o1k38fw8&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2782019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
32ea57e3a7a8c24a6d7562362bd67f87e828848016ad41059fdf283f3b8567e8

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:11 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
483
Expires
0
ud.ashx
in.ml314.com/
20 B
698 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=2782019
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2782019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.202.10.50 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-202-10-50.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:11 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, no-cache="set-cookie"
Connection
keep-alive
Content-Length
138
Expires
Sat, 28 Sep 2019 04:34:12 GMT
c9e52fb98fb2fcfc524217f74e5d616e
api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/ Frame D76B
0
0
Document
General
Full URL
https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/c9e52fb98fb2fcfc524217f74e5d616e?segments=true&mergestate=true&ts=1569558852242
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf /
Resource Hash

Request headers

:method
GET
:authority
api.lytics.io
:scheme
https
:path
/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/c9e52fb98fb2fcfc524217f74e5d616e?segments=true&mergestate=true&ts=1569558852242
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
cookie
__cfduid=d9112afb7cefb3168a140f90e13de2bb01569558852; seerid=c9e52fb98fb2fcfc524217f74e5d616e
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
access-control-allow-methods
GET
access-control-allow-origin
content-encoding
gzip
content-type
text/html
server
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf
date
Fri, 27 Sep 2019 04:34:12 GMT
content-length
294
via
1.1 google
alt-svc
clear
csync.ashx
ml314.com/
Redirect Chain
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151501698431723&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151501698431723%26eid=50056
  • https://ml314.com/csync.ashx?fp=M1lpBQ9999OeyRN5&person_id=5978151501698431723&eid=50056
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=M1lpBQ9999OeyRN5&person_id=5978151501698431723&eid=50056
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:34:13 GMT

Redirect headers

Location
https://ml314.com/csync.ashx?fp=M1lpBQ9999OeyRN5&person_id=5978151501698431723&eid=50056
Date
Fri, 27 Sep 2019 04:34:13 GMT
Connection
keep-alive
Content-Length
0
BK-Server
768c
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151501698431723
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTUwMTY5ODQzMTcyMxAAGg0IxKK27AUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=34ba23456f3a59b6912852b934c1b5192ccc8c25021aa66fbd3c55ac3cad96c3f4cb09cee1a4f8eb&person_id=5978151501698431723&eid=50082
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=34ba23456f3a59b6912852b934c1b5192ccc8c25021aa66fbd3c55ac3cad96c3f4cb09cee1a4f8eb&person_id=5978151501698431723&eid=50082
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:34:12 GMT

Redirect headers

date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
status
307
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=34ba23456f3a59b6912852b934c1b5192ccc8c25021aa66fbd3c55ac3cad96c3f4cb09cee1a4f8eb&person_id=5978151501698431723&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501698431723%26eid=50220
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151501698431723%26eid=50220&mm_bnc&mm_bct&UUID=a6ab5d8d-8bf9-4d00-853a-7fba17ded2f4
  • https://ml314.com/csync.ashx?fp=a6ab5d8d-8bf9-4d00-853a-7fba17ded2f4&person_id=5978151501698431723&eid=50220
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=a6ab5d8d-8bf9-4d00-853a-7fba17ded2f4&person_id=5978151501698431723&eid=50220
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:34:13 GMT

Redirect headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Server
MT3 1734 ed2a032 master zrh-pixel-x19
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Location
https://ml314.com/csync.ashx?fp=a6ab5d8d-8bf9-4d00-853a-7fba17ded2f4&person_id=5978151501698431723&eid=50220
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
0
Expires
Fri, 27 Sep 2019 04:34:12 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501698431723
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151501698431723
  • https://ml314.com/csync.ashx?fp=b1cbf696db8ce881be614625f59d966e&eid=50146&person_id=5978151501698431723
43 B
312 B
Image
General
Full URL
https://ml314.com/csync.ashx?fp=b1cbf696db8ce881be614625f59d966e&eid=50146&person_id=5978151501698431723
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.31.106.135 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-31-106-135.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sat, 28 Sep 2019 00:34:13 GMT

Redirect headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:13 GMT
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Location
https://ml314.com/csync.ashx?fp=b1cbf696db8ce881be614625f59d966e&eid=50146&person_id=5978151501698431723
Cache-Control
no-cache
X-Server
10.45.29.66
Connection
keep-alive
Content-Length
0
Expires
0
match
ps.eyeota.net/
Redirect Chain
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2RK9XQOLmMR1wNyXG6QeoYTMCyZNh96anvJzqOhELR0g&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil
  • https://ml314.com/csync.ashx?fp=2RK9XQOLmMR1wNyXG6QeoYTMCyZNh96anvJzqOhELR0g&person_id=5978151501698431723&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
70 B
171 B
Image
General
Full URL
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
18.197.149.199 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-197-149-199.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Content-Length
70
Content-Type
image/gif

Redirect headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html; charset=utf-8
Location
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Cache-Control
private
Connection
keep-alive
Content-Length
168
Expires
Sat, 28 Sep 2019 00:34:12 GMT
/
www.facebook.com/tr/ Frame 2AB4
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3938
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
cookie
fr=0yiQmFkH4ZwkPtS83..BdjZFE...1.0.BdjZFE.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Fri, 27 Sep 2019 04:34:12 GMT
pathfora.min.js
c.lytics.io/static/
98 KB
20 KB
Script
General
Full URL
https://c.lytics.io/static/pathfora.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac38cebe3cba0-VIE
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
5687
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:34:12 GMT
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?_ts=1569558852589&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_e=pv&utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&_sesstart=1&_tz=2&_ul=en-US&_sz=1600x1200&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38cebe4cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?publicationId=13&channel=home&pagetype=post&tags=oncology%2Crespiratory%20and%20thoracic%20cancers&categories=news&pagename=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC&author=Brian%20Park%2C%20PharmD&section=home%3Anews%3Anivolumab%20vs%20docetaxel%3A%205-year%20outcomes%20in%20patients%20with%20advanced%20nsclc&email=nguyentt%40sutterhealth.org&user_id=0&cpn=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&login=nguyentt%40sutterhealth.org&userstate=CA&userspecialty=&userprofession=Physician&_ts=1569558852589&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38cebe5cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1569558851437&event=gtm.js&gtm.uniqueEventId=15&_ts=1569558852589&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38cfc13cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.AdBlocking=&_ts=1569558852590&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38d0c24cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NHTFlag=false&_ts=1569558852590&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38d2c58cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleId=124022%3A0&_ts=1569558852590&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38dbdb3cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleType=MPR%20Drug%20News&_ts=1569558852591&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38dcdbecba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.MetaData=&_ts=1569558852591&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38ddde7cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Type=post&_ts=1569558852591&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38ddde9cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
92 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.ScrollDepth=&_ts=1569558852592&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38e0e19cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
115 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.cmeActivityId=&_ts=1569558852592&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38eaf20cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PrintSource=&_ts=1569558852592&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38ecf56cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.SEOScore=&_ts=1569558852592&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38ecf5ccba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.Prefix=omn&_ts=1569558852593&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38edf6acba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.PublicationId=13&_ts=1569558852593&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38edf80cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Author=Brian%20Park%2C%20PharmD&_ts=1569558852593&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38edf8bcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.PremiumMonograph=&_ts=1569558852594&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38f88adcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.Geolocation=&_ts=1569558852594&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38fa8e6cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
101 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Activity.Name=&_ts=1569558852594&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38fa8eacba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GenericEvents=&_ts=1569558852594&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38fb8f5cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.CurrencyCode=&_ts=1569558852595&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38fb908cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.OrderId=&_ts=1569558852595&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac38fb90acba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
269 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Drug.CompanyName=&_ts=1569558852595&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3906a8ecba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.IsPremiumMonograph=false&_ts=1569558852596&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3908ab1cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GatingType=post%3Anone&_ts=1569558852596&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3908abfcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Company=&_ts=1569558852596&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3909ac9cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Discipline=&_ts=1569558852597&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3909ad1cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
94 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Asset=&_ts=1569558852597&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac390aadacba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PublishDate=2019-09-17&_ts=1569558852597&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3914bdccba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Curation=false&_ts=1569558852598&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3916bfacba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.WordCount=330&_ts=1569558852598&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3916c07cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
230 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.CreditType=&_ts=1569558852598&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3917c1ecba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
92 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.ActivityResult=&_ts=1569558852599&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3917c22cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.NumberofAdCalls=9&_ts=1569558852599&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3918c2fcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.ProductsInCart=&_ts=1569558852599&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3922d1bcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section1=home&_ts=1569558852600&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3924d7acba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section2=home%3Anews&_ts=1569558852600&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3924d88cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section3=home%3Anews%3Anivolumab%20vs%20docetaxel%3A%205-year%20outcomes%20in%20patients%20with%20advanced%20nsclc&_ts=1569558852600&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3925dbdcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section4=&_ts=1569558852600&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3926dc4cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Tags=oncology%2Crespiratory%20and%20thoracic%20cancers&_ts=1569558852601&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3926dc7cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Categories=news&_ts=1569558852601&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3930f0ccba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.LoggedIn=false&_ts=1569558852601&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3932f5fcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Login=&_ts=1569558852601&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3932f63cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SocSSN=&_ts=1569558852602&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3933f88cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SSO=3&_ts=1569558852602&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3933f8ecba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubscriberId=0&_ts=1569558852602&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3934fa9cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Source=&_ts=1569558852602&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac393e8fccba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Profession=Physician&_ts=1569558852602&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3940934cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Specialty=&_ts=1569558852603&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac394193dcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubProfession=&_ts=1569558852603&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3941952cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubSpecialty=&_ts=1569558852603&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3942976cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.JobTitle=&_ts=1569558852604&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac39479ffcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
117 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CampaignCodes=pcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019&_ts=1569558852604&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac394caadcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
95 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Country=&_ts=1569558852604&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac394eb00cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
104 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Company=&_ts=1569558852605&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac394fb09cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CompanySize=&_ts=1569558852605&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3950b29cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsHaymarket=false&_ts=1569558852605&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3953b83cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsTracked=true&_ts=1569558852605&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac3955bbccba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsFromAim=false&_ts=1569558852605&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac395bc7fcba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
92 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NpiNumber=1619909975&_ts=1569558852606&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac395ccaecba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/
35 B
93 B
Image
General
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1569558852001&event=gtm.js&gtm.uniqueEventId=3&_ts=1569558852606&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&_uid=c9e52fb98fb2fcfc524217f74e5d616e&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
51cac395dcb7cba0-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
c9e52fb98fb2fcfc524217f74e5d616e
api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/
169 KB
29 KB
XHR
General
Full URL
https://api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/c9e52fb98fb2fcfc524217f74e5d616e?limit=30&contentsegment=ee9fe9a51cf2f1774e42f33abc9ca99c&shuffle=true
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1568281912
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf /
Resource Hash
12859b9729e6638dbeff666dfa4927a27e12c348707d9c76fc86a8848560d916

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:12 GMT
content-encoding
gzip
server
lytics.io afbca1b0bd5468a6f7b9c99405e0c6c063368ebf
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
status
200
access-control-allow-methods
GET
content-type
application/json
access-control-allow-origin
https://www.empr.com
alt-svc
clear
via
1.1 google
/
www.facebook.com/tr/ Frame 07A4
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8083:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
11534
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
cookie
fr=0yiQmFkH4ZwkPtS83..BdjZFE...1.0.BdjZFE.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Fri, 27 Sep 2019 04:34:12 GMT
Cookie set /
www.medtargetsystem.com/beacon/portal/ Frame A9A6
0
0
Document
General
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F&_sid=00c6e604-5dce-41b5-b436-9f749f08c579&_vid=1583796a-0775-42c7-a5cf-462160a1497f&_ak=35-212-8F62AC13&_flash=false&_th=1569558852|1569558852|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Host
www.medtargetsystem.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

Cache-Control
no-store, no-cache, must-revalidate
Content-Encoding
gzip
Content-Type
text/html; charset=UTF-8
Date
Fri, 27 Sep 2019 04:34:12 GMT
Expires
Thu, 19 Nov 1981 08:52:00 GMT
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Pragma
no-cache
Server
Apache/2.4.7 (Ubuntu)
Set-Cookie
DMDSESSID=ksmrn5tkvc53jp50mm2m457712; path=/; HttpOnly
Vary
X-Forwarded-Proto,Accept-Encoding
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
6989
Connection
keep-alive
collect.gif
www.medtargetsystem.com/analytics/
0
313 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=1583796a-0775-42c7-a5cf-462160a1497f&sid=00c6e604-5dce-41b5-b436-9f749f08c579&vh=1&vt=1569558852&pt=1569558852&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&r=&t=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&p=2080.71&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
css
fonts.googleapis.com/
1 KB
477 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Lato:400,900
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Fri, 27 Sep 2019 04:34:12 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Fri, 27 Sep 2019 04:34:12 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:12 GMT
truncated
/
5 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
13
subapi.haymarketmedia.com/newsletter/
3 KB
4 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
truncated
/
24 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/gif
collect.gif
www.medtargetsystem.com/analytics/
0
313 B
Image
General
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=1583796a-0775-42c7-a5cf-462160a1497f&sid=00c6e604-5dce-41b5-b436-9f749f08c579&vh=2&vt=1569558852&pt=1569558852&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&r=&t=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&p=2159.97&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
truncated
/
82 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml
pathfora.min.css
c.lytics.io/static/
20 KB
3 KB
Stylesheet
General
Full URL
https://c.lytics.io/static/pathfora.min.css
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/static/pathfora.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac38dfe0dcba0-VIE
date
Fri, 27 Sep 2019 04:34:12 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
6523
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:34:12 GMT
config.js
c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/
54 KB
8 KB
Script
General
Full URL
https://c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/config.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3c190f1fd1a6c15ba3202a789424a7fbfb9e6b3fc0a96af1e712d456fc9fd4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
51cac395ece7cba0-VIE
date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
23
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Fri, 27 Sep 2019 06:34:14 GMT
482786heartecg703035ns_964584.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
144 KB
144 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/482786heartecg703035ns_964584.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
da4f5437cface99072eaa41247090342409d9bc3ff6d0b78b00832765e02f4a8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 22:09:16 GMT
server
nginx
etag
"dd4eea9fd05ae70ec5161037b08b0bbf"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
147463
expires
Sun, 27 Oct 2019 04:34:12 GMT
genericpillsg92964678_1248233.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
133 KB
134 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/genericpillsg92964678_1248233.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
719a7e9a6d7b5858bb3e6f52044f7e3314d8e831a50558e7fde876c23b41abd7
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 09:10:04 GMT
server
nginx
etag
"18b3d88a0fc76fd4c9d4ca87bd066f99"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
136647
expires
Sun, 27 Oct 2019 04:34:12 GMT
Drug-store-blur-pharmacy-g-519039152.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/
156 KB
156 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/Drug-store-blur-pharmacy-g-519039152.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
5808e3cf46f4386637e47979371b9d84d9c78ba7fa90dbb3cb9b2b0799c2bf11
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 01 May 2019 07:10:58 GMT
server
nginx
etag
"25263397e2bdabe9188ecbaa98a13ac4"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
159262
expires
Sun, 27 Oct 2019 04:34:12 GMT
heartattackg530779559_1461739.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
21 KB
22 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/heartattackg530779559_1461739.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
51acd6cae9a2c501f05bdfaa4d52c131e4297365de18b044d92b2cc06c2bcc9e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 21:49:16 GMT
server
nginx
etag
"ee7d8347e3728bd5da4c4ec521d76a55"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
21829
expires
Sun, 27 Oct 2019 04:34:12 GMT
rezarefluxband_1420764.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
14 KB
14 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/rezarefluxband_1420764.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
b3dd27c99b51ce59dce2d0aea72a7a9454f334d5d7bb7ad941f5988bf26d39cf
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 23:39:28 GMT
server
nginx
etag
"c3178f2b8c362a720d474606bb7b70c2"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
14155
expires
Sun, 27 Oct 2019 04:34:12 GMT
logo684548_784578.png
media.empr.com/images/2015/06/11/
3 KB
4 KB
Image
General
Full URL
https://media.empr.com/images/2015/06/11/logo684548_784578.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.23 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-23.fra53.r.cloudfront.net
Software
Microsoft-IIS/8.5 /
Resource Hash
3784de1376e4cc7d2db3f624c01de2ec4b51e28f955c5d61f7fd0f2c198bd473

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 17 Sep 2019 02:26:26 GMT
via
1.1 d01ad8df731d3f120823f9e20df55147.cloudfront.net (CloudFront)
age
871495
x-cache
Hit from cloudfront
status
200
content-length
3316
last-modified
Fri, 11 Dec 2015 18:50:25 GMT
server
Microsoft-IIS/8.5
etag
"802eadcb4434d11:0"
content-type
image/png
access-control-allow-origin
*
cache-control
max-age=31536000
imagefrom
New-Image
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
x-amz-cf-id
d41IH0xf9j2-yPScP2ZwxucwQdwoeFsTgQOZuzel9Rpe83SB3mAGVg==
nosegraphicns_980642.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
121 KB
121 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/nosegraphicns_980642.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
9feff31510afc8b060065043a9b02a303762090ce40ceefab838e8e9cc8365df
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 19:50:56 GMT
server
nginx
etag
"e524eb053c5d41607a8094bfae497603"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
123811
expires
Sun, 27 Oct 2019 04:34:12 GMT
fdahq_1495688.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
44 KB
44 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/fdahq_1495688.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3622b951ea76b210435cfe0389822bfbeb3c690133e6c6fd4724c335b594420a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 21:46:08 GMT
server
nginx
etag
"281477ab9f7eb60e6b7d1f61e45fe582"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
45105
expires
Sun, 27 Oct 2019 04:34:12 GMT
blood-cells-platelets-g-899003618.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/
27 KB
27 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/blood-cells-platelets-g-899003618.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
9de61e8b65145665735db2f361b69068660c9e59b41f45ce600718ba7ce79533
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Sun, 21 Apr 2019 07:12:02 GMT
server
nginx
etag
"5cb81c80870c5b57269076963c24e535"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
27772
expires
Sun, 27 Oct 2019 04:34:12 GMT
trispharmarecall3_1513143-1024x369.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
64 KB
65 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/trispharmarecall3_1513143-1024x369.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
dd0af35e3041167ac14093ee32b0670cf791f8cfe5d07fa03375800fc630acab
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Thu, 21 Mar 2019 01:51:20 GMT
server
nginx
etag
"80c0bab99151b066fdf5a250bec4edf5"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
65856
expires
Sun, 27 Oct 2019 04:34:12 GMT
bladderg535644833_1475872.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
24 KB
24 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/bladderg535644833_1475872.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3fd1ee91b4da340917151d9204ef282a93f86f068d92b0fbb4e0ebc4fb0e43f6
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Thu, 21 Mar 2019 03:48:14 GMT
server
nginx
etag
"c22ee531576f83217ae0b749069eb9c6"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
24492
expires
Sun, 27 Oct 2019 04:34:12 GMT
stentgsb10066182j001_1524073.jpg
www.empr.com/wp-content/uploads/sites/7/2019/01/
22 KB
22 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/01/stentgsb10066182j001_1524073.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
db42605386bc604285acc739432fa65bec0ccddb102faf262d1e38a5624bece3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 09:07:01 GMT
server
nginx
etag
"d524c4ab44fa9e3e771489a1e13f2366"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
22526
expires
Sun, 27 Oct 2019 04:34:12 GMT
Money-diabetes-treatment-G-1143547033.jpg
www.empr.com/wp-content/uploads/sites/7/2019/08/
507 KB
508 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/08/Money-diabetes-treatment-G-1143547033.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
29782aa3850f5802fba4aee974e53d32f1080f9d921b896a9abd058c708e0ad2
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Tue, 03 Sep 2019 07:10:44 GMT
server
nginx
etag
"cbd592a00b1c2aa686105533f6429255"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
518941
expires
Sun, 27 Oct 2019 04:34:12 GMT
malecontraceptive_1510230.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
13 KB
13 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/malecontraceptive_1510230.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
02e592bd9850243d6ededc0592ca39bad84eb15e812d65fa3819af1e0ba81c62
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Thu, 21 Mar 2019 01:48:23 GMT
server
nginx
etag
"a0e87f76d58c42816053c05a9261986b"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
13312
expires
Sun, 27 Oct 2019 04:34:12 GMT
Stomachache-G-697606479.jpg
www.empr.com/wp-content/uploads/sites/7/2019/02/
18 KB
18 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/02/Stomachache-G-697606479.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
4c23a1aafa857a5769b25ee50e6364518e5b25096dc44fba8a8c6cba6159f629
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 09:13:56 GMT
server
nginx
etag
"60cca6cdda067f7f0e44d9b1f62c5c7a"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
18314
expires
Sun, 27 Oct 2019 04:34:12 GMT
drugupdate_1500043.png
www.thecardiologyadvisor.com/wp-content/uploads/sites/17/2019/01/
210 KB
210 KB
Image
General
Full URL
https://www.thecardiologyadvisor.com/wp-content/uploads/sites/17/2019/01/drugupdate_1500043.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2fcdf1e8d2e68c7fba89406381fe92100fa6a3d75b0032bc511b4464d46aa6a8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:14 GMT
last-modified
Mon, 25 Mar 2019 07:34:18 GMT
server
nginx
etag
"3a07e8bdcbfc141ce904cc41af0284b2"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
214804
expires
Sun, 27 Oct 2019 04:34:14 GMT
Binx-io-STI-test.jpg
www.empr.com/wp-content/uploads/sites/7/2019/08/
21 KB
22 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/08/Binx-io-STI-test.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
63586a7bf085002326142b92c151021ad99d4c6dcf2a097764ca7d5b83a0a420
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Sat, 24 Aug 2019 07:10:57 GMT
server
nginx
etag
"d22a113137e6a8b743481f97ad7a26b7"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
21984
expires
Sun, 27 Oct 2019 04:34:12 GMT
depressionmddg728909107_1410912.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
14 KB
14 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/depressionmddg728909107_1410912.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8ff24692e7395fae9138c4bb78c2bbb4d4923cae0d9f2720dee3a7e2d62d3a03
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 21:42:15 GMT
server
nginx
etag
"223adb647bdda684b3b59babf32dd296"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
14347
expires
Sun, 27 Oct 2019 04:34:13 GMT
cysticfibrosiswordcloudss_1279773.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
32 KB
32 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/cysticfibrosiswordcloudss_1279773.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6454824b40507a03604db2ce37c11b5dc1474e65df280f40910e43c2f4536858
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:12 GMT
last-modified
Wed, 20 Mar 2019 09:16:54 GMT
server
nginx
etag
"69af2a6bf043e47c07951983dd10f68b"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
32818
expires
Sun, 27 Oct 2019 04:34:12 GMT
imfinzi_1215044.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
396 KB
396 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/imfinzi_1215044.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
397486cc51c9de9801c4edd9fb26b4ff81b25b770528ef43cd5ebebb6c541b13
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 21:40:53 GMT
server
nginx
etag
"bcc532d51fe6cfece965d6933a3fb75f"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
405197
expires
Sun, 27 Oct 2019 04:34:13 GMT
FDA-logo-FI.png
www.empr.com/wp-content/uploads/sites/7/2019/07/
426 KB
427 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/07/FDA-logo-FI.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
92f43f03582b5fa6ab35f37ba18f5e9b532fe6105c262a7ad0879bd1b3a565c7
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Sat, 10 Aug 2019 07:11:11 GMT
server
nginx
etag
"ebd14b1e1b6d11a26972094f1799ed78"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
436575
expires
Sun, 27 Oct 2019 04:34:13 GMT
orphandrugns_1001134.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
99 KB
99 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/orphandrugns_1001134.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
98a61fed7de6a5c75832311d91304c00452e1d6cd6f7a52c6caf2fe0ae5e6ae3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Thu, 21 Mar 2019 01:48:21 GMT
server
nginx
etag
"2a5dcea17f36dac1ec0834d867995982"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
100894
expires
Sun, 27 Oct 2019 04:34:13 GMT
cardio-heart_456274.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
57 KB
58 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/cardio-heart_456274.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
978e6f2b4488e4fad883b34c9bf4d9068dfbdc4dbdfd2f5b9c364765ecfe179c
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 23:40:35 GMT
server
nginx
etag
"32817c8b8da32ae36125e6d1388bf657"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
58839
expires
Sun, 27 Oct 2019 04:34:13 GMT
uexplorerimagescanner_1525301.jpg
www.empr.com/wp-content/uploads/sites/7/2019/02/
8 KB
8 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/02/uexplorerimagescanner_1525301.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
36419a82deca7b9c003c2eb870c3fa68923cf7dbefc8b3309c4b5e4136f8113c
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 09:12:24 GMT
server
nginx
etag
"e89be2664333f634f28132605750dabc"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
7918
expires
Sun, 27 Oct 2019 04:34:13 GMT
belviq_1477881.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
7 KB
7 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/belviq_1477881.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
b0abfbbc3b3f06f000fddfb4069520bfc3c5f4d212baf76e0180076eafeb7f25
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 21:55:29 GMT
server
nginx
etag
"0e75b424f96259ea05ac27b943f597f4"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
6907
expires
Sun, 27 Oct 2019 04:34:13 GMT
heartanatomyss233628424_1182563.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
186 KB
187 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/heartanatomyss233628424_1182563.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
571f0d2fbc5d9e206f4493f5ba110a70b1c55077bc9110e8d8b5bcb115cb9140
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 09:16:15 GMT
server
nginx
etag
"d7925ae0238bfedb07e5d889271d9e81"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
190920
expires
Sun, 27 Oct 2019 04:34:13 GMT
cerealeatingg969909714_1445607.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
24 KB
24 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/cerealeatingg969909714_1445607.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6159b0200e37d2e301ecb7a7d74f90a2992bd1ae87740322f293af4c4efc2e4e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 19:42:38 GMT
server
nginx
etag
"6a081b7666a6f0dd9a1b1b42d3e518a0"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
24239
expires
Sun, 27 Oct 2019 04:34:13 GMT
FDA-HQ.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/
44 KB
44 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/FDA-HQ.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3622b951ea76b210435cfe0389822bfbeb3c690133e6c6fd4724c335b594420a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 17 Apr 2019 07:11:10 GMT
server
nginx
etag
"281477ab9f7eb60e6b7d1f61e45fe582"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
45105
expires
Sun, 27 Oct 2019 04:34:13 GMT
psoriaticarthritischalkboard_1274840.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/
43 KB
43 KB
Image
General
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/psoriaticarthritischalkboard_1274840.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.0.128.45 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-0-128-45.compute-1.amazonaws.com
Software
nginx /
Resource Hash
f8d01ec910b326a38c827a7ad81338b72df1e3e51602f72d108ecaeff2d83160
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Fri, 27 Sep 2019 04:34:13 GMT
last-modified
Wed, 20 Mar 2019 21:58:03 GMT
server
nginx
etag
"917b47dbe027ae6bbc98084871e68f0b"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
44009
expires
Sun, 27 Oct 2019 04:34:13 GMT
registration-profession
subapi.haymarketmedia.com/
589 B
876 B
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/
2 KB
2 KB
XHR
General
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.209.234.104 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-209-234-104.compute-1.amazonaws.com
Software
/ Express
Resource Hash
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
truncated
/
88 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml;charset=utf-8
ads
securepubads.g.doubleclick.net/gampad/
4 KB
2 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3036209018226395&correlator=212995236493521&output=ldjh&callback=googletag.impl.pubads.callbackProxy1&impl=fif&adsid=NT&eid=21064578%2C21062833%2C21064580&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2FOOP_prestitial&sz=1x1&ists=1&scp=pos%3DOOP_prestitial&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124022%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1569558853&dt=1569558853089&dlt=1569558851432&idt=636&frm=20&biw=1585&bih=1200&oid=3&adx=0&ady=3944&adk=1518026067&uci=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=77&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1585x3945&msz=1585x1&ga_vid=1264205446.1569558852&ga_sid=1569558853&ga_hid=1133661135&fws=4&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
06b9d9cc46aa5c3d03668ac12987d7a0afa78a48b53d73c5d33d58380e616786
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1966
x-xss-protection
0
google-lineitem-id
132788185
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138287632758
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019091901.js
securepubads.g.doubleclick.net/gpt/
62 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
a29b20518a3bb583278ebb330cba43e072795b7009b39f3479819d00f0833064
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 19 Sep 2019 13:07:51 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24151
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:13 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

universal-tag.js
ads.spotible.com/tag/ Frame 9592
4 KB
2 KB
Script
General
Full URL
https://ads.spotible.com/tag/universal-tag.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
8a846df9c01f4d8d8b6e82c6e505069104280430b3b05d94a13a5b99d7c854aa

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:12 GMT
Content-Encoding
gzip
ETag
"5c736e518f66ceaaee6badc00016e1a5"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=3600
Connection
keep-alive
Content-Length
1767
truncated
/ Frame 9592
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8078f30af1a2126a191e32648a989d6b438dd9cb7ee13abf029e225ae594ab9d

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
218087ed3854e672a6627b47c86b3a97e1dad722daa9f509fe522b33b01302a2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29169
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:13 GMT
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
362 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:7a00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
via
1.1 ad93a72606d0015c6aa5ceae5dc8a8d5.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
29b7883f-7ffc-49c3-ae45-ef69e6e2c27a
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9145-a631fcd44ae63a144df66130;Sampled=0
x-amz-apigw-id
AqOi8EooIAMF8kQ=
content-length
2
x-amz-cf-id
120gIDAqTUxD2KPbfUdEOAvul0GSsA5ycA1GBVamWcrl2cwlY8gbMw==
ads
securepubads.g.doubleclick.net/gampad/
9 KB
4 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3036209018226395&correlator=212995236493521&output=ldjh&callback=googletag.impl.pubads.callbackProxy2&impl=fif&adsid=NT&eid=21064578%2C21062833%2C21064580&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fleaderboard_top&sz=728x90&scp=pos%3Dleaderboard_top%26amid%3D%26atype%3DMPR_Drug_News%26author%3DSteve%2520Duffy%26block%3DHMN_Tecfidera_2019%2Cmpr_basaglar042616%26browser%3DChrome%252074%26cat%3DOncology%2CRespiratory_and_Thoracic_Cancers%26comp%3D%26env%3Dlive%26isnht%3Dfalse%26pagetype%3Dpost%26postID%3D124022%26sid%3DNews%26sponsor%3D%26spr%3D%26ssp%3D%26styleid%3D&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124022%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D4f9743eee0a74c8d%3AT%3D1569558853%3AS%3DALNI_MZiXS7t-MnEoY6rkw1pg54oIVOUXw&cookie_enabled=1&bc=31&abxe=1&lmt=1569558853&dt=1569558853709&dlt=1569558851432&idt=636&frm=20&biw=1585&bih=1200&oid=3&adx=193&ady=140&adk=2785330797&uci=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=78&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1200x-1&msz=1200x-1&psts=Ci8I2d-oP-gB9qLXlIMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QI25cxrZOzwfQ&ga_vid=1264205446.1569558852&ga_sid=1569558853&ga_hid=1133661135&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
ded787d307257999d20cc27597ebe8c922bcf141711aac7f998a280cf43781e8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
3293
x-xss-protection
0
google-lineitem-id
5144421111
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138278274851
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
error_handler.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame DA70
7 KB
3 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/error_handler.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
8065cef9d51cead6f70a4d96a9e5c10474aefa816094212ec32d0dba396fc880
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 24 Sep 2019 13:57:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
225399
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
3342
x-xss-protection
0
server
cafe
etag
1345723656027342843
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 08 Oct 2019 13:57:34 GMT
delayed_impression_vu_simple_fetch_fy2019.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/impression/ Frame DA70
0
0

spam_signals_bundle_fy2019.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/spam_signals/ Frame DA70
0
0

15638570741095414737
tpc.googlesyndication.com/simgad/ Frame DA70
30 KB
30 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/15638570741095414737
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
892ff0b3166742d839aeb9027057d0bd3f0e9af48d70cbfa44f22952f9c1fcf0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 02 Sep 2019 13:22:21 GMT
x-content-type-options
nosniff
age
2128312
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
30632
x-xss-protection
0
last-modified
Wed, 07 Aug 2019 16:56:48 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 01 Sep 2020 13:22:21 GMT
window_focus_fy2019.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame DA70
0
0

osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame DA70
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
6182dfae0694d2f06ce0ba9e18b21af30bdc62b4878767761059e6f03cba08e5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:13 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29692
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:13 GMT
l
www.google.com/ads/measurement/ Frame DA70
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQroL3LJdGS_9FIhhO4S9NXpxi2t6RQmyrU8t5z6ygeszp7Dl4x0fb-QGWK6tDLejMSf_iD06KEGlkg2yJLYDNzO-4AJQ
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame DA70
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776212071&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278274851&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
6db5a878acf25380c3767c82d224e940e97469b54b6e8a8f97f303115230ea6e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
ads
securepubads.g.doubleclick.net/gampad/
20 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3036209018226395&correlator=212995236493521&output=ldjh&callback=googletag.impl.pubads.callbackProxy3&impl=fif&adsid=NT&eid=21064578%2C21062833%2C21064580&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_1&sz=300x250%7C300x600&scp=pos%3Dbox_1%26LyticsSegments%3Dga_med_nomycme%2Cga_med_nht_false%2Cmycme_rheum_survey_audience%2Cmycme_4638_audience%2Conc_town_wall_audience%2Con_town_wall_audience_use_this%2Con_town_wall_audience_use_this_no_gastro%2C3_day_visitors_neuro_ca_empr%2Cblackfriday_notunknown%2Cactivity_5126_audience%2Cmycme_endofyearsale_noanonymous_nosdc%2Caudience_for_mlk_sale%2Cnot_unknown_5770%2Cmycme_activity_5762%2Call%2Csmt_new%2Cly_reporting_from_email%2Cly_reporting_has_visited_web%2Cly_reporting_multi_session_visitor%2Cly_reporting_last_visit_within_day%2Cly_reporting_last_visit_within_week%2Cly_reporting_last_visit_within_month%2Cly_reporting_last_visit_within_3_months%2Cly_known_email%2Cly_repeat_visitor%2Cly_international_visitor%2Cly_uses_desktop%2Cly_from_email%2Cknown%2Call_time_visitors%2Cmycme_allergy_all_except_4797_completes%2Cmycme_hiv_all_except_4670_completes%2Cmycme_internal_med_all_except_4670_completes%2Cmycme_allergy_all_except_4744_completes%2Cmycme_psychiatry_all_except_4812_completes%2Cmycme_cardiology_all_except_cardiology_pas%2Cmycme_dermatology_all_except_4831_completes%2Cmycme_pediatrics_all_except_4354_completes%2Cmycme_acc_next_activity_promo_no_4523%2Cmycme_acc_next_activity_promo_no_4524%2Cmycme_acc_next_activity_promo_no_4525%2Cmycme_acc_next_activity_promo_no_4526%2Cmycme_acc_next_activity_promo_no_4593%2Cmycme_acc_next_activity_promo_no_4595%2Cmycme_acc_next_activity_promo_no_4710%2Cmycme_acc_next_activity_promo_no_4804%2Cmycme_acc_next_activity_promo_no_4834%2Cmycme_acc_next_activity_promo_no_4800%2Cmycme_acc_next_activity_promo_no_4792%2Cmycme_acc_next_activity_promo_no_4511%2Cmycme_acc_next_activity_promo_no_4529%2Cmycme_acc_next_activity_promo_no_4558%2Cmycme_acc_next_activity_promo_no_4634%2Cmycme_impact_next_activity_promo_no_4740%2Cmycme_impact_next_activity_promo_no_4757%2Cmycme_impact_next_activity_promo_no_4842%2Cmycme_impact_next_activity_promo_no_4816%2Cmycme_impact_next_activity_promo_no_4897%2Cmycme_impact_next_activity_promo_no_4727%2Cmycme_impact_next_activity_promo_no_4755%2Cmycme_impact_next_activity_promo_no_4791%2Cmycme_impact_next_activity_promo_no_47911%2Cmycme_impact_next_activity_promo_no_4826%2Cmycme_impact_next_activity_promo_no_4815%2Cce_excluding_mpr_print_subscribers%2Cce_excluding_ca_print_subscribers%2Cga_med_known%2Cnace_conversations_in_onc_ona%2Cmycme_homepage_ibs_town_wall_%2Cmycme_ddw_nash%2Cmycme_cll_may_16%2Cemailops060619%2Cmycme_activity_5841_2%2Cmycme_pediatrics_activity_5591%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26atype%3DMPR_Drug_News%26author%3DSteve%2520Duffy%26block%3DHMN_Tecfidera_2019%2Cmpr_basaglar042616%26browser%3DChrome%252074%26cat%3DOncology%2CRespiratory_and_Thoracic_Cancers%26comp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26env%3Dlive%26isnht%3Dfalse%26pagetype%3Dpost%26postID%3D124022%26sid%3DNews%26sponsor%3D%26spr%3D448%26ssp%3D%26styleid%3D%26subid%3D0%26usrc%3Dhaymarket%26lid%3D5144421111&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124022%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D4f9743eee0a74c8d%3AT%3D1569558853%3AS%3DALNI_MZiXS7t-MnEoY6rkw1pg54oIVOUXw&cookie_enabled=1&bc=31&abxe=1&lmt=1569558853&dt=1569558853923&dlt=1569558851432&idt=636&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=305&adk=204078694&uci=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=77&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&psts=Ci8I2d-oP-gB9qLXlIMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QI25cxrZOzwfQ%2CCjAI98WGlRPoAaOOnJCDBIICFbG5gA_RufYhgcP2IfHtzzTnwNqPUdECsPy4MJG5MDk&ga_vid=1264205446.1569558852&ga_sid=1569558853&ga_hid=1133661135&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
8f2ba1f81a998c713851be2d25308d263b678d6fb473a142e2487bc084765783
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:14 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
5705
x-xss-protection
0
google-lineitem-id
5144421111
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138278274593
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame DA70
0
58 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=jserror&context=535&msg=ReferenceError%3A%20init_ssb%20is%20not%20defined%0Aat%20https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653%3A1%3A1114&eid=259053400%2C453877036&jc=29&eids=259053400%2C453877036&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:13 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
delayed_impression_vu_simple_fetch_fy2019.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/impression/ Frame DA70
0
0

spam_signals_bundle_fy2019.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/spam_signals/ Frame DA70
0
0

creative-delivery.js
ads.spotible.com/creative/aiv6/
58 KB
20 KB
Script
General
Full URL
https://ads.spotible.com/creative/aiv6/creative-delivery.js
Requested by
Host: ads.spotible.com
URL: https://ads.spotible.com/tag/universal-tag.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
8bb87b6a883fd75428afe9c39a568eea8415cb06565b55f77483dcfedf440290

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:13 GMT
Content-Encoding
gzip
ETag
"c009dc01c1c99388f07743f6b22a012f"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
no-cache
Connection
keep-alive
Content-Length
19906
gen_204
pagead2.googlesyndication.com/pagead/ Frame DA70
0
58 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=jserror&context=535&msg=ReferenceError%3A%20init_ssb%20is%20not%20defined%0Aat%20https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653%3A1%3A2962&eid=259053400%2C453877036&jc=29&eids=259053400%2C453877036&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame DA70
0
58 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=jserror&context=535&msg=ReferenceError%3A%20vu%20is%20not%20defined%0Aat%20https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653%3A1%3A4321&eid=259053400%2C453877036&jc=29&eids=259053400%2C453877036&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame DA70
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b56ec3d46f732014e041fd1fecdb77ff7f9b2b6d5a348114b4598d446902dab7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame 8416
0
75 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsueukiquG4I3jAoa3Y1jJgcD4rVtEgoBntEr7eyJEgvP0fbsgrTtEOgvZoT8yOGi_bw-JLqWkeKunbjQgP_16uvkb2oS86lgQJYWk1kjQ5g0yg5K9UlGeS8NPH2p_wPFb2PEZ4X9Ql_TzKTNai75KFexnAxVdzeroZ9tAoijURKxHSp3ttzcFMuTRZgwHQFnGbpNAXWoquCP1uwBr-as3O-aityjNYZaf9kyBPJPa2rh1Jg-rmrQE0g_iWHtoFpaRvNnOvZdCMp5w&sig=Cg0ArKJSzPuWgMGVe-i7EAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:34:14 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame 8416
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 24 Sep 2019 13:57:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
225401
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 08 Oct 2019 13:57:33 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 8416
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
6182dfae0694d2f06ce0ba9e18b21af30bdc62b4878767761059e6f03cba08e5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29692
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:14 GMT
l
www.google.com/ads/measurement/ Frame 8416
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaToSNEeFBtGa277xawIKvAI27121m3WJxnGZAem23ufQRlNhUc3eV1VdKnQ7r9Prm0jlatmzCAN1CoLKVdsgwNwFdMg8Q
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 8416
13 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031401&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278274593&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
fa540ccfd42e64bde56950c65c2f69bcb3203db60e87f6a79b772f6469cf9aa0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
4489233149016687223
tpc.googlesyndication.com/simgad/ Frame 8416
41 KB
41 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/4489233149016687223
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f984c8e1978cf73d7c628f6d255ced232aab616cd77fcf720d5afb6b98fe4725
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sat, 24 Aug 2019 15:07:56 GMT
x-content-type-options
nosniff
age
2899578
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42317
x-xss-protection
0
last-modified
Wed, 07 Aug 2019 16:56:46 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 23 Aug 2020 15:07:56 GMT
ads
securepubads.g.doubleclick.net/gampad/
22 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3036209018226395&correlator=212995236493521&output=ldjh&callback=googletag.impl.pubads.callbackProxy4&impl=fif&adsid=NT&eid=21064578%2C21062833%2C21064580&vrg=2019091901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190927&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fbox_2&sz=300x250&scp=pos%3Dbox_2%26LyticsSegments%3Dga_med_nomycme%2Cga_med_nht_false%2Cmycme_rheum_survey_audience%2Cmycme_4638_audience%2Conc_town_wall_audience%2Con_town_wall_audience_use_this%2Con_town_wall_audience_use_this_no_gastro%2C3_day_visitors_neuro_ca_empr%2Cblackfriday_notunknown%2Cactivity_5126_audience%2Cmycme_endofyearsale_noanonymous_nosdc%2Caudience_for_mlk_sale%2Cnot_unknown_5770%2Cmycme_activity_5762%2Call%2Csmt_new%2Cly_reporting_from_email%2Cly_reporting_has_visited_web%2Cly_reporting_multi_session_visitor%2Cly_reporting_last_visit_within_day%2Cly_reporting_last_visit_within_week%2Cly_reporting_last_visit_within_month%2Cly_reporting_last_visit_within_3_months%2Cly_known_email%2Cly_repeat_visitor%2Cly_international_visitor%2Cly_uses_desktop%2Cly_from_email%2Cknown%2Call_time_visitors%2Cmycme_allergy_all_except_4797_completes%2Cmycme_hiv_all_except_4670_completes%2Cmycme_internal_med_all_except_4670_completes%2Cmycme_allergy_all_except_4744_completes%2Cmycme_psychiatry_all_except_4812_completes%2Cmycme_cardiology_all_except_cardiology_pas%2Cmycme_dermatology_all_except_4831_completes%2Cmycme_pediatrics_all_except_4354_completes%2Cmycme_acc_next_activity_promo_no_4523%2Cmycme_acc_next_activity_promo_no_4524%2Cmycme_acc_next_activity_promo_no_4525%2Cmycme_acc_next_activity_promo_no_4526%2Cmycme_acc_next_activity_promo_no_4593%2Cmycme_acc_next_activity_promo_no_4595%2Cmycme_acc_next_activity_promo_no_4710%2Cmycme_acc_next_activity_promo_no_4804%2Cmycme_acc_next_activity_promo_no_4834%2Cmycme_acc_next_activity_promo_no_4800%2Cmycme_acc_next_activity_promo_no_4792%2Cmycme_acc_next_activity_promo_no_4511%2Cmycme_acc_next_activity_promo_no_4529%2Cmycme_acc_next_activity_promo_no_4558%2Cmycme_acc_next_activity_promo_no_4634%2Cmycme_impact_next_activity_promo_no_4740%2Cmycme_impact_next_activity_promo_no_4757%2Cmycme_impact_next_activity_promo_no_4842%2Cmycme_impact_next_activity_promo_no_4816%2Cmycme_impact_next_activity_promo_no_4897%2Cmycme_impact_next_activity_promo_no_4727%2Cmycme_impact_next_activity_promo_no_4755%2Cmycme_impact_next_activity_promo_no_4791%2Cmycme_impact_next_activity_promo_no_47911%2Cmycme_impact_next_activity_promo_no_4826%2Cmycme_impact_next_activity_promo_no_4815%2Cce_excluding_mpr_print_subscribers%2Cce_excluding_ca_print_subscribers%2Cga_med_known%2Cnace_conversations_in_onc_ona%2Cmycme_homepage_ibs_town_wall_%2Cmycme_ddw_nash%2Cmycme_cll_may_16%2Cemailops060619%2Cmycme_activity_5841_2%2Cmycme_pediatrics_activity_5591%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26atype%3DMPR_Drug_News%26author%3DSteve%2520Duffy%26block%3DHMN_Tecfidera_2019%2Cmpr_basaglar042616%26browser%3DChrome%252074%26cat%3DOncology%2CRespiratory_and_Thoracic_Cancers%26comp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26env%3Dlive%26isnht%3Dfalse%26pagetype%3Dpost%26postID%3D124022%26sid%3DNews%26sponsor%3D%26spr%3D448%26ssp%3D%26styleid%3D%26subid%3D0%26usrc%3Dhaymarket%26lid%3D5144421111&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DSteve%2520Duffy%26postID%3D124022%26env%3Dlive%26sid%3DNews%26styleid%3D%26cat%3DOncology%252CRespiratory_and_Thoracic_Cancers%26atype%3DMPR_Drug_News%26block%3DHMN_Tecfidera_2019%252Cmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D7ae510fe18e7431582eb749cfc8567497d75868fa53d079af4ef35f92eebbf33%26spr%3D448%26ssp%3D%26cpn%3Dpcp_md%252Cfp_md%252Cpcp_all%252Charvonitbg%252Cepclusalistb_jan2019%252Cepclusa_april_2019%26subid%3D0%26usrc%3Dhaymarket%26eid%3D4765f0213a10614f6c52b4556676d479ec4f181705feaedbccdcef78c850b74a%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252Cmycme_4638_audience%252Conc_town_wall_audience%252Con_town_wall_audience_use_this%252Con_town_wall_audience_use_this_no_gastro%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_known_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Cknown%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_known%252Cnace_conversations_in_onc_ona%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_cll_may_16%252Cemailops060619%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D4f9743eee0a74c8d%3AT%3D1569558853%3AS%3DALNI_MZiXS7t-MnEoY6rkw1pg54oIVOUXw&cookie_enabled=1&bc=31&abxe=1&lmt=1569558854&dt=1569558854145&dlt=1569558851432&idt=636&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=826&adk=3917873969&uci=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&dssz=79&icsg=152282360446980&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x283&msz=300x250&psts=CjAI98WGlRPoAaGMnJCDBIICFbG5gA_RufYhgcP2IfHtzzSpvc-PUdECm1VVg14STtY%2CCi8I2d-oP-gB9qLXlIMEggIVsbmAD9G59iGBw_Yh8e3PNLfIz49R0QI25cxrZOzwfQ%2CCjAI98WGlRPoAaOOnJCDBIICFbG5gA_RufYhgcP2IfHtzzTnwNqPUdECsPy4MJG5MDk&ga_vid=1264205446.1569558852&ga_sid=1569558853&ga_hid=1133661135&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
597b7ea5554dcfc1f8500c25be83fb04f340652ecfc0f717d243295e51559d86
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:14 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
6373
x-xss-protection
0
google-lineitem-id
5144421111
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138278213337
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
MPR-lightbox_640x480_Sept_1_.png
cdn1.spotible.com/hashed/65b04db536233c88899551573fc5aa10/
193 KB
194 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/65b04db536233c88899551573fc5aa10/MPR-lightbox_640x480_Sept_1_.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.75 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-75.fra53.r.cloudfront.net
Software
/
Resource Hash
7a1eaf913cf2579fc6b89d3a474cc9def653fa4d36702569d75b54fce2502519

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 18 Sep 2019 11:41:09 GMT
via
1.1 6080b2713e502211e152f21f5c59c5a7.cloudfront.net (CloudFront)
age
145124
etag
"65b04db536233c88899551573fc5aa10"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
197880
x-amz-cf-id
2sQQR_97VONS2PidK0B7v7dCFqo-Wkgcm_NduFS1IdSabafgObAl5Q==
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
364 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:7a00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 ad93a72606d0015c6aa5ceae5dc8a8d5.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
71c595ad-7753-4bc3-a6a9-251eca0fd134
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9146-98966c1ca8c5deae557d3547;Sampled=0
x-amz-apigw-id
AqOjDE17oAMFSOg=
content-length
2
x-amz-cf-id
vv7QQMVJzmpWRVI9is0Fl4PaTTBTUsZ1L-ewXTg_UpNK-yS6ewxCLg==
truncated
/ Frame 8416
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9cb6303fd67063c516439e357f2ef23dfbc29da3a59f9c9865c384819cb948b5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
error_handler.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame E76F
7 KB
3 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/error_handler.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
8065cef9d51cead6f70a4d96a9e5c10474aefa816094212ec32d0dba396fc880
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 24 Sep 2019 13:57:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
225400
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
3342
x-xss-protection
0
server
cafe
etag
1345723656027342843
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 08 Oct 2019 13:57:34 GMT
11395196143614127256
tpc.googlesyndication.com/simgad/ Frame E76F
44 KB
45 KB
Image
General
Full URL
https://tpc.googlesyndication.com/simgad/11395196143614127256
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f5b21fd9753166a8dabf7c360c5af3f8d7009d5f9b2f1918ef615d9e13624169
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 13 Sep 2019 09:30:25 GMT
x-content-type-options
nosniff
age
1191829
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
45438
x-xss-protection
0
last-modified
Wed, 07 Aug 2019 16:56:30 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Sat, 12 Sep 2020 09:30:25 GMT
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/ Frame E76F
2 KB
1 KB
Script
General
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
d31b12baad65082a7d404da9971cc9fed871e35f29a5893f815f468f1050491f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 24 Sep 2019 13:57:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
225401
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
1044
x-xss-protection
0
server
cafe
etag
16885093947315342629
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Tue, 08 Oct 2019 13:57:33 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame E76F
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
6182dfae0694d2f06ce0ba9e18b21af30bdc62b4878767761059e6f03cba08e5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:34:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1569237451959804"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29692
x-xss-protection
0
expires
Fri, 27 Sep 2019 04:34:14 GMT
l
www.google.com/ads/measurement/ Frame E76F
0
0
Image
General
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaQA94GTkPD43vE3A3YA4UHg-fByMs1aeX4i7o035VeAUundaIoMn-lEE9UkfVqc-WeMDyN9c0evRtnqzDuYjjnRIENYMg
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:820::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame E76F
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21776031404&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278213337&CPN=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&sid=News
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019091901.js?21064578
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
683f03860189200c2f3c715f4106fd564f65f751655eb674ef759374ed3e4f51

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:14 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
view
securepubads.g.doubleclick.net/pcs/ Frame E76F
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsv5rWCSZtGMqNthHYK_HDE3AzLC79dN0Ne8XIbUb0X_L0a8MIzhUHKyiTWhf5aSaHFcrwB1HoT6Jq15ix8q13RtivT9ylkdi85ZgtSJe0oNEVmwW2JrS1ReQ2nh90NhHC7ixasAaBMZ6-oFvnwCL2pc9WhMkqNgvfVKDWURbSRgdDkkZNfwPYVPTBEQlRjvJZHd_EBFT21R_WajG-MwEW0zlm7wQE7JXAlA1mdgt2E0jPiMIG2nDnhK9wHzgHR5_vPVaBSiA_DAiw&sig=Cg0ArKJSzHYrPt6uDYQoEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:34:14 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
truncated
/ Frame E76F
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
fc992b366c4d4f844098898de36b43f4e52c878b5b12e7cdc4a90109caad0994

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
366 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:7a00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:34:14 GMT
via
1.1 ad93a72606d0015c6aa5ceae5dc8a8d5.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
2dbce09b-9cb6-4593-ad31-a151506b5974
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9146-761b2998fdfd2dffa26aebf9;Sampled=0
x-amz-apigw-id
AqOjFFXbIAMFndQ=
content-length
2
x-amz-cf-id
QgfiIC44W8DzBZTUX03iv71cRITaQqoJMcBVcTkJ2ESVRCEQ8zHI_w==
ad.gif
api-54-245-184-141.b2c.com/api/ Frame 8416
43 B
233 B
Image
General
Full URL
https://api-54-245-184-141.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:23c6:3b85:d7f5:6913 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:14 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
/
adtrackapi.haymarketmedia.com/adverttracking/
2 B
364 B
XHR
General
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20bb:7a00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Fri, 27 Sep 2019 04:34:15 GMT
via
1.1 ad93a72606d0015c6aa5ceae5dc8a8d5.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA56
x-amzn-requestid
a44feaaf-b188-4998-84a9-40e09b8b7913
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d8d9147-c6e27161d4608b09f4b609a8;Sampled=0
x-amz-apigw-id
AqOjIE7zIAMFdPQ=
content-length
2
x-amz-cf-id
l0LqcPvGxBqR11bA9LlerhwaGGj1UJoIxuweykYNE7q7nkcmqemKRQ==
ad.gif
api-34-219-221-191.b2c.com/api/ Frame E76F
43 B
233 B
Image
General
Full URL
https://api-34-219-221-191.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:dbb0:2341:5b61:3e04 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:15 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
report
ads.spotible.com/creative/aiv6/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/aiv6/report?,1569558854,101001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!2,1,0
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:14 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
48 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssHGYDrcd8qTwo-7LnmkVzFVnFcCBe3Wx8mrITqKcz89oz0Ucj56T4Q5gvVfCpMb1OQ-JbSvswkBG-PAiGQ_CGA45a4zI2IQi5Sed7B1DItjbZ6qSWEkgd4mcUHahqoT7bgXN-Je2TAxvS2jwTzU6xYjLS8j5Sl9TrWkC5xvjSwqkgZ5dDIGYMh58yNpVnqmXL-n5ckOdbIkraOTt5M237bivu5Dj9V-0EGQygcusxt1wYZ4BaqfyqDUtOseHYWXkKBr3T74SmMgx1j7IAXS3aKxjH2jzjCsE3DnkW0cUsn6xodN1O4o2nwBvUlvg&sai=AMfl-YTR0-t9Wgidx66IKxvDesCobKd880nRbPIFyq-yZKISGwcByzEcLA0tPKzaDYy3JJmNPBYjeK4RxJShLSi6ktPRSkYhY89LlECujXkg&sig=Cg0ArKJSzHz3gyfqn2VwEAE&urlfix=1&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Fri, 27 Sep 2019 04:34:14 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
ad.gif
api-35-166-13-162.b2c.com/api/ Frame DA70
43 B
233 B
Image
General
Full URL
https://api-35-166-13-162.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:18fd:5331:bb62:1421 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:15 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
4
api-54-245-184-141.b2c.com/api/ Frame 8416
Redirect Chain
  • https://api-54-245-184-141.b2c.com/api/x?etqib3p9aTEaLXl1$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL25pdm9sdW1hYi12cy1kb2NldGF4ZWwtNS15ZWFyLW91dGNvbWVzLWluLXBhdGllbnRzLXdpdGgtYWR2YW5jZWQtbnN...
  • https://api-54-245-184-141.b2c.com:444/api/4?etqib3p9aTEaLXl1
43 B
441 B
XHR
General
Full URL
https://api-54-245-184-141.b2c.com:444/api/4?etqib3p9aTEaLXl1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.245.184.141 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-245-184-141.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:17 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 27 Sep 2019 04:34:15 GMT
Server
openresty
Location
https://api-54-245-184-141.b2c.com:444/api/4?etqib3p9aTEaLXl1
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-34-219-221-191.b2c.com/api/ Frame E76F
Redirect Chain
  • https://api-34-219-221-191.b2c.com/api/x?3GPX0VNSMyR66jQt$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL25pdm9sdW1hYi12cy1kb2NldGF4ZWwtNS15ZWFyLW91dGNvbWVzLWluLXBhdGllbnRzLXdpdGgtYWR2YW5jZWQtbnN...
  • https://api-34-219-221-191.b2c.com:444/api/4?3GPX0VNSMyR66jQt
0
0

4
api-35-166-13-162.b2c.com/api/ Frame DA70
Redirect Chain
  • https://api-35-166-13-162.b2c.com/api/x?MU8eTtoZbjjRInus$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL25pdm9sdW1hYi12cy1kb2NldGF4ZWwtNS15ZWFyLW91dGNvbWVzLWluLXBhdGllbnRzLXdpdGgtYWR2YW5jZWQtbnNj...
  • https://api-35-166-13-162.b2c.com:444/api/4?MU8eTtoZbjjRInus
0
0

activeview
pagead2.googlesyndication.com/pcs/ Frame DA70
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstdZAf0Bhib0TDVTy3lh31RlCz32PG8VM6NzPCSWZHCc57ttpOOl_Z7loFICFgSfzzebnUAKNjvkApQ2CcFtGwHHBSAieDfAvatEZuUwR4&sig=Cg0ArKJSzAQB8pxQCX7YEAE&adk=2785330797&tt=-1&bs=1585%2C1200&mtos=1020,1020,1020,1020,1020&tos=1020,0,0,0,0&p=140,429,230,1157&mcvt=1020&rs=3&ht=0&tfs=414&tls=1434&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=288&niot_cbk=302&md=2&lm=2&rst=1569558853919&rpt=60&isd=0&msd=0&oseid=3&xdi=0&ps=1585%2C4034&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-4-6-15-12-53-14-0-0-0&tvt=1427&r=v&id=osdim&vs=4&za&uc=11&upc=0&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=728x90&itpl=3&v=20190923
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:15 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
x
api-54-245-184-141.b2c.com/api/ Frame 8416
0
382 B
Other
General
Full URL
https://api-54-245-184-141.b2c.com/api/x?etqib3p9aTEaLXl1$YWRibG9jayQ1MzckMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:23c6:3b85:d7f5:6913 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:15 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
rum.js
securepubads.g.doubleclick.net/pagead/js/ Frame E76F
49 KB
19 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/pagead/js/rum.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
2e15e692bea3c6fc994ef5c32f26e978be3ae8c1716545f87f44d148c813893b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 04:10:25 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1430
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
19041
x-xss-protection
0
server
cafe
etag
6910878246990244881
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Fri, 27 Sep 2019 05:10:25 GMT
csi
csi.gstatic.com/ Frame E76F
0
56 B
Other
General
Full URL
https://csi.gstatic.com/csi?v=2&s=pagead&action=csi_pagead&dmc=8&puid=1~k11mtfm6&ctx=2&gqid=RpGNXaqtCsTYgAeovJv4Dg&qqid=CIGx1K-W8OQCFRM84Aodf60Lpw&met.4=fb.a~lb.1e~ol.p8~idt.dd~dt.-4b&met.3=197.1d~123.1c_1~118.1g~118.1g~118.1l~118.1m~118.4f~118.79~118.a2~118.cv~118.fp~118.ii~118.ld~118.o6~117.p8~118.p8~113.qb_3~112.qa_4&met.1=1.k11mtevw~14.0~15.0~16.0~17.0~18.0~19.0~20.p8~21.p8~22.g~23.g&met.7=CBwQChgBIAIoAjAIOAdoAnAIeNkagAGOGogBkTuwAQG4AQM~CBcQBhgBIAIoAjAKOAhoA3AJeI3kAoAB_uICiAH-4gKwAQG4AQM~CBwQChgBIAIoAjAJOAdoA3AJeNoIgAGUCIgBnRKwAQG4AQM~CCoQChgBIAIoAjAtOCo~CBsQBhgBIAIoAjAQOA4~CBsQCiACOOwC~CCIQBBgBIAwoDDArOCBoDHAreDmwAQG4AQM~CBsQBiD_AjiNBA~CCgQChgBII0HKI0HMK8HOCJojQdwogd4lJYBgAHhlAGIAd6FA7ABAbgBAw
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/js/rum.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2607:f8b0:4002:c09::5e , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:15 GMT
last-modified
Wed, 21 Jan 2004 19:51:30 GMT
server
Golfe2
status
204
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 8416
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstEdJOOBhmCz4uyySkPBASf8-2xF6owe4213ff32v2SNkGQ05dTqFvSdZ7vujxHBEpbrPPCzkzOXsY0o8SfiQyHsH3_oYcsSuiijIPgbcI&sig=Cg0ArKJSzG-1jZqXSbOkEAE&adk=204078694&tt=-1&bs=1585%2C1200&mtos=1014,1014,1014,1014,1014&tos=1014,0,0,0,0&p=305,1053,555,1353&mcvt=1014&rs=3&ht=0&tfs=623&tls=1637&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=510&niot_cbk=522&md=2&lm=2&rst=1569558854141&rpt=50&isd=0&msd=0&oseid=3&xdi=0&ps=1585%2C4034&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-4-7-17-12-63-16-0-0-0&tvt=1630&r=v&id=osdim&vs=4&za&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x250&itpl=3&v=20190923
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:15 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
Cookie set rt=ifr
bcp.crwdcntrl.net/5/c=14413/rand=724066507/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%2... Frame A0D5
0
0
Document
General
Full URL
https://bcp.crwdcntrl.net/5/c=14413/rand=724066507/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/med=%23OpR%2397539%23Article%20Tags%20%3A%20Oncology%2CRespiratory%20and%20Thoracic%20Cancers/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653%22%7D/rt=ifr
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.250.208.218 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-250-208-218.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Host
bcp.crwdcntrl.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Accept-Encoding
gzip, deflate, br
Cookie
_cc_dc=1; _cc_id=b1cbf696db8ce881be614625f59d966e; _cc_cc="ACZ4nGNQSDJMTkozszRLSbJITrWwMExKNTM0MTMyTTO1TLE0M0tlAILY3omuDAgAAGXRCuw%3D"; _cc_aud="ABR4nGNgYGCI7Z3oygAHABYUAcE%3D"
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

Access-Control-Allow-Origin
*
Cache-Control
no-cache
Content-Encoding
gzip
Content-Type
text/html;charset=UTF-8
Date
Fri, 27 Sep 2019 04:34:15 GMT
Expires
0
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Pragma
no-cache
Set-Cookie
_cc_id=b1cbf696db8ce881be614625f59d966e;Path=/;Domain=crwdcntrl.net;Expires=Tue, 23-Jun-2020 04:06:00 GMT;SameSite=None _cc_cc="ACZ4nGNQSDJMTkozszRLSbJITrWwMExKNTM0MTMyTTO1TLE0M0tlAILY3onu%2F%2F7%2F%2F8%2FPAAPc12e2KDKeLWD4z8jIcGoygt07HcG%2B%2FPyOLIy9f%2FlROPvWSXUY89KpR2ww9uHFc1hg7AdTexhh7OUfLWHMC0hKAO%2FXPs0%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 23-Jun-2020 04:06:00 GMT;Max-Age=23328000;SameSite=None _cc_aud="ABR4nGNgYGCI7Z3ozgADTAwcV2pBDI7bh4AkAEYoBMM%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 23-Jun-2020 04:06:00 GMT;Max-Age=23328000;SameSite=None
Vary
Accept-Encoding
X-Server
10.45.29.66
Content-Length
657
Connection
keep-alive
cs.js
sb.scorecardresearch.com/c2/21948019/
0
400 B
Script
General
Full URL
https://sb.scorecardresearch.com/c2/21948019/cs.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:15 GMT
Content-Encoding
gzip
Last-Modified
Fri, 08 Apr 2011 23:11:26 GMT
ETag
"d41d8cd98f00b204e9800998ecf8427e:1349196464"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=259200
Connection
keep-alive
Content-Length
20
Expires
Mon, 30 Sep 2019 04:34:15 GMT
init-121b5si20pnxjymcwdz.js
api.b2c.com/api/
12 KB
5 KB
Script
General
Full URL
https://api.b2c.com/api/init-121b5si20pnxjymcwdz.js?isNHT=false
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
2fefc31038db59a4b74b4d3fa4383e96d831331cc9fadd40602175bcc96e7050

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:15 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1133661135&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-n...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_gid=1796489758.1569558855&gjid=82973732&_v=j79&z=1880946211
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_v=j79&z=1880946211
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_v=j79&z=1880946211&slf_rd=1&random=427057369
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_v=j79&z=1880946211&slf_rd=1&random=427057369
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:15 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:15 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1264205446.1569558852&jid=2098950621&_v=j79&z=1880946211&slf_rd=1&random=427057369
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
up
insight.adsrvr.org/track/ Frame 113E
0
0
Document
General
Full URL
https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&upid=7fhq4wn&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.51.120.75 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-51-120-75.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
insight.adsrvr.org
:scheme
https
:path
/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&upid=7fhq4wn&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653

Response headers

status
200
date
Fri, 27 Sep 2019 04:34:16 GMT
content-type
text/html
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
collect
www.google-analytics.com/
35 B
109 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1133661135&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-spotlight-hay-20190927%26cpn%3Dpcp_md%2Cfp_md%2Cpcp_all%2Charvonitbg%2Cepclusalistb_jan2019%2Cepclusa_april_2019%26hmSubId%3D%26hmEmail%3D8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1%26NID%3D1619909975%26c_id%3D%26email_hash%3D13fcf80b8097eed186e07db19fd3c2c6%26dl%3D0%26mpweb%3D1323-68826-2303653&ul=en-us&de=UTF-8&dt=Nivolumab%20vs%20Docetaxel%3A%205-Year%20Outcomes%20in%20Patients%20With%20Advanced%20NSCLC%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=Scroll%20Depth&ea=%2Fhome%2Fnews%2Fnivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc%2F&el=25%25&ev=25&_u=aGjAAAAjQ~&jid=&gjid=&cid=1264205446.1569558852&tid=UA-1290429-2&_gid=1796489758.1569558855&gtm=2wg9i15XFK9V6&z=858162407
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 02 Sep 2019 11:01:56 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
2136739
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
x
api-34-219-221-191.b2c.com/api/ Frame E76F
0
382 B
Other
General
Full URL
https://api-34-219-221-191.b2c.com/api/x?3GPX0VNSMyR66jQt$YWRibG9jayQ1MzYkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:dbb0:2341:5b61:3e04 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:15 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-35-166-13-162.b2c.com/api/ Frame DA70
0
382 B
Other
General
Full URL
https://api-35-166-13-162.b2c.com/api/x?MU8eTtoZbjjRInus$YWRibG9jayQ1MjkkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:18fd:5331:bb62:1421 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:15 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame E76F
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsuWkRB8blzmNT-kx1xTUBUleGy34VC20us1IIaSabFaM5bYKgJP3a-PSIIWhdxUTci-xtIY-bY2h6XjmYIz4kf-XANGVGJXhDraJ-xbY8g&sig=Cg0ArKJSzPr5VJmaWgHbEAE&adk=3917873969&tt=-1&bs=1585%2C1200&mtos=1015,1015,1015,1015,1015&tos=1015,0,0,0,0&p=826,1053,1076,1353&gcm=1&lcs=1&mcvt=1015&rs=3&ht=0&tfs=724&tls=1739&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=672&niot_cbk=683&md=2&lm=2&rst=1569558854303&rpt=48&isd=0&msd=0&oseid=3&xdi=0&ps=1585%2C4034&ss=1600%2C1200&pt=-1&bin=1&deb=1-1-4-7-18-12-67-17-0-0-0&tvt=1731&r=v&id=osdim&vs=4&za&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x250&itpl=3&v=20190923
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 27 Sep 2019 04:34:15 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ad.gif
api-54-245-184-141.b2c.com/api/
43 B
233 B
Image
General
Full URL
https://api-54-245-184-141.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:23c6:3b85:d7f5:6913 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:15 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
4
api-54-245-184-141.b2c.com/api/
Redirect Chain
  • https://api-54-245-184-141.b2c.com/api/x?MIm1Xl62paofqMpJ$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL25pdm9sdW1hYi12cy1kb2NldGF4ZWwtNS15ZWFyLW91dGNvbWVzLWluLXBhdGllbnRzLXdpdGgtYWR2YW5jZWQtbnN...
  • https://api-54-245-184-141.b2c.com:444/api/4?MIm1Xl62paofqMpJ
43 B
441 B
XHR
General
Full URL
https://api-54-245-184-141.b2c.com:444/api/4?MIm1Xl62paofqMpJ
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.245.184.141 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-245-184-141.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Fri, 27 Sep 2019 04:34:17 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Fri, 27 Sep 2019 04:34:15 GMT
Server
openresty
Location
https://api-54-245-184-141.b2c.com:444/api/4?MIm1Xl62paofqMpJ
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
close_button2.png
cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/
1 KB
2 KB
Image
General
Full URL
https://cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/close_button2.png
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.75 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-75.fra53.r.cloudfront.net
Software
/
Resource Hash
f42e34b205a7c2ac4a0997e0b1eb2627e76ee8ae15ac7a15b05954827e186dd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 17 Sep 2019 08:54:47 GMT
via
1.1 6080b2713e502211e152f21f5c59c5a7.cloudfront.net (CloudFront)
age
236812
etag
"74483a4bff0849849588dbf32a396fe9"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
1429
x-amz-cf-id
Ip1oWRRt-io9ccSgEAkCJODmzZDFwHM7fXeMml_yjlhHkrYkYovYdw==
report
ads.spotible.com/creative/aiv6/
43 B
191 B
Image
General
Full URL
https://ads.spotible.com/creative/aiv6/report?,1569558854,101003;IMPRESSION!4,1,0!5,1,0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/nivolumab-vs-docetaxel-5-year-outcomes-in-patients-with-advanced-nsclc/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-spotlight-hay-20190927&cpn=pcp_md,fp_md,pcp_all,harvonitbg,epclusalistb_jan2019,epclusa_april_2019&hmSubId=&hmEmail=8t85OaMnAtdseYl1KsHVWpeVp1w148tbPcMzAuUck5E1&NID=1619909975&c_id=&email_hash=13fcf80b8097eed186e07db19fd3c2c6&dl=0&mpweb=1323-68826-2303653
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Fri, 27 Sep 2019 04:34:18 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/impression/delayed_impression_vu_simple_fetch_fy2019.js
Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/spam_signals/spam_signals_bundle_fy2019.js
Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/client/window_focus_fy2019.js
Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/impression/delayed_impression_vu_simple_fetch_fy2019.js
Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/pagead/js/r20190924/r20110914/elements/html/spam_signals/spam_signals_bundle_fy2019.js
Domain
api-34-219-221-191.b2c.com
URL
https://api-34-219-221-191.b2c.com:444/api/4?3GPX0VNSMyR66jQt
Domain
api-35-166-13-162.b2c.com
URL
https://api-35-166-13-162.b2c.com:444/api/4?MU8eTtoZbjjRInus

Verdicts & Comments Add Verdict or Comment

200 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate number| pamEnabled object| hmAds object| dataLayer object| $ function| jQuery function| cookie object| _cc14413 object| LOTCC object| Digest function| UtilityMove object| core object| __core-js_shared__ object| global object| System function| asap function| Observable function| setImmediate function| clearImmediate object| regeneratorRuntime boolean| _babelPolyfill object| googletag object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken object| google_tag_manager string| GoogleAnalyticsObject function| ga string| adTrackProxyPath string| advertTrackingApiUrl boolean| trackImpressionsViewable object| clickedAd boolean| isOverIFrame object| dfpRequests function| waitFor function| DataLayerExist function| AdSlotsRegistered function| TrackPassbackImpression function| TrackImpression function| TrackImpressionViewable function| AdClick function| checkDuplicateImpression function| callApi function| AmazonWebService function| createAdTrackingMessage function| getAJAXObject function| trackAdvert function| xdTrackAdvert function| getRenderedAd function| EventType function| getPageDetails function| getPageName function| getSection1 function| getPageType function| getDevice function| getValueFromTargets function| getPageTypeId function| getBrowser function| getUser function| getDfpTimestamp function| getCookies function| getTimeStamp function| ProcessMouseOut function| ProcessMouseOver function| processIFrameClick function| getDfpUrlFor function| getDfpUrls function| logAdvertRequested object| dataLayerService function| hmHeaderLoginState object| dfpAdSlots object| mapping object| adSlotsConfig object| allowedSlots string| hmHomeUrl string| hmAccountUrl object| hmRegisteredAds boolean| hmAdsLazyload number| hmAdsActiveRefresh boolean| hmAdsCommentsHouse boolean| hmDmdAimEnabled boolean| hmProclivityEnabled boolean| hmAdsActiveRefreshAll boolean| hmAdsBoxReposition boolean| hmAdsLytics object| adSlots number| adDebug object| hmProclivity string| cpn object| haymarketCustomEvents object| google_tag_data object| gaplugins object| gaGlobal object| gaData string| redirect object| CE2 string| __INDIVIDUAL_ONE_VERSION_ev-store_ENFORCE_SINGLETON undefined| __INDIVIDUAL_ONE_VERSION_ev-store object| epas function| maropostInitTracking string| name_funnel function| _132350 string| name_funnel1 function| _13235 object| data object| ids object| epasAPI object| hm_localize object| hm_gated object| date function| isStorageSupported function| truncateItem function| storeData function| removeData function| retrieveData function| readStorage function| getExpiration object| TenUp object| liosetup object| jstag object| hmAuthNoncePromise function| disqus_config object| hmRegisterPrompt function| hmSetLyticsData object| adblockDetector object| pageVars object| _atrk_opts function| fbq function| _fbq function| retry function| isIE10OrLater function| detectPrivateMode object| wp function| hmOpenRegisterPrompt object| AIM object| _ml object| google_optimize function| __jstag_onload undefined| initObj string| ly_cid undefined| google_measure_js_timing boolean| google_noFetch number| __google_ad_urls_id function| webpackJsonp object| ns_ function| atrk boolean| _atrk_fired object| lio string| set_domain function| domain_name function| deleteMaroClickScriptTag function| maroRecordClick function| anchor_event_add function| maroRecordTime function| maroTrackInit object| optimizely object| _0xee07 function| _0x5513 function| HMIRegistration object| ssoLogin object| ssoRegister object| pathfora number| google_unique_id object| google_reactive_ads_global_state function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| prontoTags object| ProntoCE function| ttd_dom_ready function| TTDUniversalPixelApi object| ProntoDOMEvents object| gtm string| string1 string| string2 string| string3 string| string4 string| string5 string| string6 string| string7 string| string8 string| string9 string| string10 number| lySegmentCounter string| result string| key function| checkForCPNSegments function| logit function| __$PP

9 Cookies

Domain/Path Name / Value
www.empr.com/ Name: PathforaTest_853e3ee5e01881b83ab49fe8c2eae359
Value: 0.8556137015108796
www.medtargetsystem.com/ Name: DMDSESSID
Value: lfch3hestg1na34j6s8ci8bh00
www.empr.com/ Name: PathforaTest_845520b7c2ad6c7b2d753bf3b76b1546
Value: 0.7998381538952068
www.empr.com/ Name: PathforaTest_48455487baba85f52d70e65e52b8f2d2
Value: 0.9031456615555036
.empr.com/ Name: __gads
Value: ID=4f9743eee0a74c8d:T=1569558853:S=ALNI_MZiXS7t-MnEoY6rkw1pg54oIVOUXw
www.empr.com/ Name: PathforaTest_33a33bdd982117e2cd8a1be673315252
Value: 0.5917940756551758
www.empr.com/ Name: PathforaTest_d32aacecfe87458780ba0a5b22e84019
Value: 0.6373974927250723
www.empr.com/ Name: dmd-ahk
Value: 8be3b5a83b
www.empr.com/ Name: dmd-00c6e604-5dce-41b5-b436-9f749f08c579
Value: e30=

84 Console Messages

Source Level URL
Text
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1(Line 2)
Message:
JQMIGRATE: Migrate is installed, version 1.4.1
console-api log URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js(Line 540)
Message:
interactive
console-api log (Line 2)
Message:
DMD AIM data:{}
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log (Line 8)
Message:
logit -ga_med_nomycme
console-api log (Line 8)
Message:
logit -ga_med_nht_false
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_rheum_survey_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_4638_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(onc_town_wall_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(on_town_wall_audience_use_this)
console-api log (Line 6)
Message:
checkForCPNSegments(on_town_wall_audience_use_this_no_gastro)
console-api log (Line 6)
Message:
checkForCPNSegments(3_day_visitors_neuro_ca_empr)
console-api log (Line 6)
Message:
checkForCPNSegments(blackfriday_notunknown)
console-api log (Line 6)
Message:
checkForCPNSegments(activity_5126_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_endofyearsale_noanonymous_nosdc)
console-api log (Line 6)
Message:
checkForCPNSegments(audience_for_mlk_sale)
console-api log (Line 6)
Message:
checkForCPNSegments(not_unknown_5770)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5762)
console-api log (Line 8)
Message:
logit -all
console-api log (Line 6)
Message:
checkForCPNSegments(all)
console-api log (Line 6)
Message:
checkForCPNSegments(smt_new)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_has_visited_web)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_multi_session_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_day)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_week)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_month)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_3_months)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_known_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_repeat_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_international_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_uses_desktop)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(known)
console-api log (Line 6)
Message:
checkForCPNSegments(all_time_visitors)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4797_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_hiv_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_internal_med_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4744_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_psychiatry_all_except_4812_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cardiology_all_except_cardiology_pas)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_dermatology_all_except_4831_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_all_except_4354_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4523)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4524)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4525)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4526)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4593)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4595)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4710)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4804)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4834)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4800)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4792)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4511)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4529)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4558)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4634)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4740)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4757)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4842)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4816)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4897)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4727)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4755)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4791)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_47911)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4826)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4815)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_mpr_print_subscribers)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_ca_print_subscribers)
console-api log (Line 8)
Message:
logit -ga_med_known
console-api log (Line 6)
Message:
checkForCPNSegments(nace_conversations_in_onc_ona)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_homepage_ibs_town_wall_)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_ddw_nash)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cll_may_16)
console-api log (Line 6)
Message:
checkForCPNSegments(emailops060619)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5841_2)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_activity_5591)
console-api log (Line 5)
Message:
OK
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] exiting test loop - value: false

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
accounts.haymarketmedia.com
ads.spotible.com
adservice.google.com
adservice.google.de
adtrackapi.haymarketmedia.com
api-34-219-221-191.b2c.com
api-35-166-13-162.b2c.com
api-54-245-184-141.b2c.com
api.b2c.com
api.lytics.io
bcp.crwdcntrl.net
c.lytics.io
cdn1.spotible.com
certify.alexametrics.com
connect.facebook.net
content.maropost.com
csi.gstatic.com
d31qbv1cthcecs.cloudfront.net
fonts.googleapis.com
fonts.gstatic.com
idsync.rlcdn.com
in.ml314.com
insight.adsrvr.org
js.adsrvr.org
link.email.empr.com
media.empr.com
ml314.com
mpct1.maropost.com
mt.sitomobile.com
pagead2.googlesyndication.com
pixel.mathtag.com
pixel.tapad.com
ps.eyeota.net
s3.amazonaws.com
sb.scorecardresearch.com
script.crazyegg.com
securepubads.g.doubleclick.net
sp.sitomobile.com
stats.g.doubleclick.net
subapi.haymarketmedia.com
sync.crwdcntrl.net
tags.bluekai.com
tags.crwdcntrl.net
tpc.googlesyndication.com
www.empr.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medtargetsystem.com
www.thecardiologyadvisor.com
api-34-219-221-191.b2c.com
api-35-166-13-162.b2c.com
tpc.googlesyndication.com
104.111.241.32
143.204.207.113
143.204.214.113
143.204.214.23
143.204.214.50
143.204.214.75
172.217.16.194
18.197.149.199
2.18.233.201
2.19.43.224
2600:1f14:e96:5800:18fd:5331:bb62:1421
2600:1f14:e96:5800:23c6:3b85:d7f5:6913
2600:1f14:e96:5802:3864:1186:98a:22d7
2600:1f14:e96:5802:dbb0:2341:5b61:3e04
2600:9000:20bb:7a00:16:bc48:4dc0:93a1
2600:9000:20bb:c000:1b:fadc:b780:93a1
2606:4700:20::6819:5365
2606:4700::6813:9308
2607:f8b0:4002:c09::5e
2a00:1450:4001:806::2002
2a00:1450:4001:806::200a
2a00:1450:4001:80b::2002
2a00:1450:4001:80b::2003
2a00:1450:4001:815::200e
2a00:1450:4001:81a::2003
2a00:1450:4001:81a::2008
2a00:1450:4001:81d::2002
2a00:1450:4001:81f::2001
2a00:1450:4001:820::2004
2a00:1450:400c:c00::9c
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8083:face:b00c:0:25de
3.209.234.104
34.192.84.248
34.197.62.58
34.202.10.50
34.225.65.223
34.250.208.218
35.190.72.21
35.227.192.113
35.227.248.159
35.238.92.4
52.0.128.45
52.1.219.33
52.216.171.93
52.31.106.135
52.51.120.75
54.156.255.160
54.245.184.141
93.184.220.113
94.31.29.64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